Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Osteoporosis

  Free Subscription


Articles published in Osteoporos Int

Retrieve available abstracts of 541 articles:
HTML format



Single Articles


    July 2022
  1. HA J, Kim J, Jeong C, Lim Y, et al
    Effect of follow-up raloxifene therapy after denosumab discontinuation in postmenopausal women.
    Osteoporos Int. 2022;33:1591-1599.
    PubMed     Abstract available


    June 2022
  2. TRAN O, Silverman S, Xu X, Bonafede M, et al
    Correction to: Long-term direct and indirect economic burden associated with osteoporotic fracture in US postmenopausal women.
    Osteoporos Int. 2022 Jun 29. pii: 10.1007/s00198-022-06410.
    PubMed    


  3. PAN B, Cai J, Zhao P, Liu J, et al
    Relationship between prevalence and risk of osteoporosis or osteoporotic fracture with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Osteoporos Int. 2022 Jun 28. pii: 10.1007/s00198-022-06459.
    PubMed     Abstract available


  4. MCCLOSKEY EV, Chotiyarnwong P, Harvey NC, Lorentzon M, et al
    Population screening for fracture risk in postmenopausal women - a logical step in reducing the osteoporotic fracture burden?
    Osteoporos Int. 2022 Jun 28. pii: 10.1007/s00198-022-06419.
    PubMed    


  5. ABDALBARY M, Sobh M, Elnagar S, Elhadedy MA, et al
    Management of osteoporosis in patients with chronic kidney disease.
    Osteoporos Int. 2022 Jun 24. pii: 10.1007/s00198-022-06462.
    PubMed     Abstract available


  6. BONLOKKE SE, Rand MS, Haddock B, Arup S, et al
    Baseline bone turnover marker levels can predict change in bone mineral density during antiresorptive treatment in osteoporotic patients: the Copenhagen bone turnover marker study.
    Osteoporos Int. 2022 Jun 21. pii: 10.1007/s00198-022-06457.
    PubMed     Abstract available


  7. DUONG LT, Clark S, Pickarski M, Giezek H, et al
    Effects of odanacatib on bone-turnover markers in osteoporotic postmenopausal women: a post hoc analysis of the LOFT study.
    Osteoporos Int. 2022 Jun 17. pii: 10.1007/s00198-022-06406.
    PubMed     Abstract available


  8. ZHANG F, Wang Z, Su H, Zhao H, et al
    Effect of a home-based resistance exercise program in elderly participants with osteoporosis: a randomized controlled trial.
    Osteoporos Int. 2022 Jun 15. pii: 10.1007/s00198-022-06456.
    PubMed     Abstract available


  9. TALEVSKI J, Sanders KM, Lal A, Watts JJ, et al
    A micro-costing analysis of post-fracture care pathways: results from the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS).
    Osteoporos Int. 2022 Jun 15. pii: 10.1007/s00198-022-06460.
    PubMed     Abstract available


  10. BAILEY S, Mhango G, Lin JJ
    The impact of bone mineral density screening on incident fractures and healthcare resource utilization among postmenopausal breast cancer survivors treated with aromatase inhibitors.
    Osteoporos Int. 2022 Jun 14. pii: 10.1007/s00198-022-06458.
    PubMed     Abstract available


  11. PASKINS Z, Babatunde O, Sturrock A, Toh LS, et al
    Supporting patients to get the best from their osteoporosis treatment: a rapid realist review of what works, for whom, and in what circumstance.
    Osteoporos Int. 2022 Jun 11. pii: 10.1007/s00198-022-06453.
    PubMed     Abstract available


  12. XIAO PL, Cui AY, Hsu CJ, Peng R, et al
    Global, regional prevalence, and risk factors of osteoporosis according to the World Health Organization diagnostic criteria: a systematic review and meta-analysis.
    Osteoporos Int. 2022 Jun 10. pii: 10.1007/s00198-022-06454.
    PubMed     Abstract available


  13. ROSS BJ, Ross AJ, Lee OC, Waters TL, et al
    Osteoporosis management and secondary fragility fracture rates in patients with multiple sclerosis: a matched cohort study.
    Osteoporos Int. 2022 Jun 7. pii: 10.1007/s00198-022-06451.
    PubMed     Abstract available


  14. GOLD LS, Cody RF Jr, Tan WK, Marcum ZA, et al
    Osteoporosis identification among previously undiagnosed individuals with vertebral fractures.
    Osteoporos Int. 2022 Jun 3. pii: 10.1007/s00198-022-06450.
    PubMed     Abstract available


  15. ALOIA JF, Islam S
    Trabecular bone score in PODA, a Randomized Controlled Trial (RCT) in older African American Women.
    Osteoporos Int. 2022;33:1411-1412.
    PubMed    


  16. JACOB JJ, Paul TV
    Romosozumab and cardiovascular safety-should we learn lessons from pioglitazone?
    Osteoporos Int. 2022;33:1397-1399.
    PubMed    


  17. TOMINAGA A, Wada K, Okazaki K, Nishi H, et al
    Response to Letter. "Romosozumab and cardiovascular safety- should we learn lessons from Pioglitazone?."
    Osteoporos Int. 2022;33:1401-1402.
    PubMed    


  18. COSMAN F, Kendler DL, Langdahl BL, Leder BZ, et al
    Romosozumab and antiresorptive treatment: the importance of treatment sequence.
    Osteoporos Int. 2022;33:1243-1256.
    PubMed     Abstract available


    May 2022
  19. CHOO YW, Mohd Tahir NA, Mohamed Said MS, Li SC, et al
    Cost-effectiveness of Denosumab for the Treatment of Postmenopausal Osteoporosis in Malaysia.
    Osteoporos Int. 2022 May 31. pii: 10.1007/s00198-022-06444.
    PubMed     Abstract available


  20. VANDENPUT L, Johansson H, McCloskey EV, Liu E, et al
    Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan.
    Osteoporos Int. 2022 May 31. pii: 10.1007/s00198-022-06435.
    PubMed     Abstract available


  21. RIVERA-PAREDEZ B, Quezada-Sanchez AD, Robles-Rivera K, Hidalgo-Bravo A, et al
    Dietary inflammatory index and bone mineral density in Mexican population.
    Osteoporos Int. 2022 May 28. pii: 10.1007/s00198-022-06434.
    PubMed     Abstract available


  22. LEE K, Al Jumaily K, Lin M, Siminoski K, et al
    Dual-energy x-ray absorptiometry scanner mismatch in follow-up bone mineral density testing.
    Osteoporos Int. 2022 May 26. pii: 10.1007/s00198-022-06438.
    PubMed     Abstract available


  23. SAHOTA A, Barbary R, Cameron M, Stewart AM, et al
    Safety of zoledronate in older patients at high risk of fracture with reduced renal function.
    Osteoporos Int. 2022 May 23. pii: 10.1007/s00198-022-06427.
    PubMed    


  24. BELAYA Z, Melnichenko G, Golounina O, Tsoriev T, et al
    Three-year progress report of Bone Health TeleECHO Moscow: a strategy to improve the care of patients with osteoporosis and other metabolic skeletal diseases in underserved communities of Russia.
    Osteoporos Int. 2022 May 20. pii: 10.1007/s00198-022-06431.
    PubMed     Abstract available


  25. KONG XK, Zhao ZY, Zhang D, Xie R, et al
    Major osteoporosis fracture prediction in type 2 diabetes: a derivation and comparison study.
    Osteoporos Int. 2022 May 18. pii: 10.1007/s00198-022-06425.
    PubMed     Abstract available


  26. TSAKNAKIS K, Jackle K, Luders KA, Lorenz HM, et al
    Reduced bone mineral density in adolescents with Duchenne Muscular Dystrophy (DMD) and scoliosis.
    Osteoporos Int. 2022 May 18. pii: 10.1007/s00198-022-06416.
    PubMed     Abstract available


  27. KONSTANTELOS N, Rzepka AM, Burden AM, Cheung AM, et al
    Fracture definitions in observational osteoporosis drug effects studies that leverage healthcare administrative (claims) data: a scoping review.
    Osteoporos Int. 2022 May 17. pii: 10.1007/s00198-022-06395.
    PubMed     Abstract available


  28. BRUELL S, Nicholls KM, Hewitson TD, Talbot AS, et al
    Reduced hip bone mineral density is associated with high levels of calciprotein particles in patients with Fabry disease.
    Osteoporos Int. 2022 May 16. pii: 10.1007/s00198-022-06420.
    PubMed     Abstract available


  29. HAYDEN AC, Binkley N, Krueger D, Bernatz JT, et al
    Effect of degeneration on bone mineral density, trabecular bone score and CT Hounsfield unit measurements in a spine surgery patient population.
    Osteoporos Int. 2022 May 12. pii: 10.1007/s00198-022-06407.
    PubMed     Abstract available


  30. SHABANI F, Tsinaslanidis G, Thimmaiah R, Khatak M, et al
    Correction to: Effect of institution volume on mortality and outcomes in osteoporotic hip fracture care.
    Osteoporos Int. 2022 May 3. pii: 10.1007/s00198-022-06323.
    PubMed    


    April 2022
  31. LEBOFF MS, Greenspan SL, Insogna KL, Lewiecki EM, et al
    The clinician's guide to prevention and treatment of osteoporosis.
    Osteoporos Int. 2022 Apr 28. pii: 10.1007/s00198-021-05900.
    PubMed     Abstract available


  32. CARBALLIDO-GAMIO J, Posadzy M, Wu PH, Kenny K, et al
    People living with HIV have low trabecular bone mineral density, high bone marrow adiposity, and poor trabecular bone microarchitecture at the proximal femur.
    Osteoporos Int. 2022 Apr 27. pii: 10.1007/s00198-022-06405.
    PubMed     Abstract available


  33. ZHANG X, Xu Y, Li F, Chen M, et al
    Associations between bone mineral density and subclinical peripheral arterial disease in elderly men with type 2 diabetes mellitus.
    Osteoporos Int. 2022 Apr 22. pii: 10.1007/s00198-022-06404.
    PubMed     Abstract available


  34. JOHANSSON L, Johansson H, Axelsson KF, Litsne H, et al
    Improved fracture risk prediction by adding VFA-identified vertebral fracture data to BMD by DXA and clinical risk factors used in FRAX.
    Osteoporos Int. 2022 Apr 22. pii: 10.1007/s00198-022-06387.
    PubMed     Abstract available


  35. ZENG X, Su Y, Tan A, Zou L, et al
    The association of coffee consumption with the risk of osteoporosis and fractures: a systematic review and meta-analysis.
    Osteoporos Int. 2022 Apr 15. pii: 10.1007/s00198-022-06399.
    PubMed     Abstract available


  36. HILIGSMANN M, Li N, Cooper C, Reginster JY, et al
    Improving the reporting of economic evaluation in osteoporosis: the value of CHEERS 2022 statement.
    Osteoporos Int. 2022 Apr 12. pii: 10.1007/s00198-022-06400.
    PubMed    


  37. XU W, Wu W, Yang S, Chen T, et al
    Correction to: Risk of osteoporosis and fracture after hysterectomies without oophorectomies: a systematic review and pooled analysis.
    Osteoporos Int. 2022 Apr 6. pii: 10.1007/s00198-022-06397.
    PubMed    


  38. KIM D, Pirshahid AA, Li Y, Varghese T, et al
    Prevalence of osteoporosis in osteoarthritis: a systematic review and meta-analysis.
    Osteoporos Int. 2022 Apr 5. pii: 10.1007/s00198-022-06376.
    PubMed     Abstract available


  39. HARRIS RJ, Parimi N, Cawthon PM, Strotmeyer ES, et al
    Associations of components of sarcopenia with risk of fracture in the Osteoporotic Fractures in Men (MrOS) study.
    Osteoporos Int. 2022 Apr 5. pii: 10.1007/s00198-022-06390.
    PubMed     Abstract available


  40. DU EZ, Wang YXJ
    CT detects more osteoporotic endplate depressions than radiograph: a descriptive comparison of 76 vertebrae.
    Osteoporos Int. 2022 Apr 4. pii: 10.1007/s00198-022-06391.
    PubMed     Abstract available


  41. MINISOLA S, Cipriani C, Vigna E, Sonato C, et al
    COVID pandemic and denosumab adherence.
    Osteoporos Int. 2022;33:943-944.
    PubMed    


  42. EBINA K, Etani Y, Tsuboi H, Nagayama Y, et al
    Effects of prior osteoporosis treatment on the treatment response of romosozumab followed by denosumab in patients with postmenopausal osteoporosis.
    Osteoporos Int. 2022 Apr 1. pii: 10.1007/s00198-022-06386.
    PubMed     Abstract available



  43. IOF REGIONAL 2021 8th Asia Pacific Osteoporosis Conference: Author Index.
    Osteoporos Int. 2022;33.
    PubMed    



  44. IOF REGIONAL 2021 8th Asia Pacific Osteoporosis Conference : Poster Abstracts.
    Osteoporos Int. 2022;33.
    PubMed    



  45. IOF REGIONAL 2021 8th Asia Pacific Osteoporosis Conference: Oral Communication Abstracts.
    Osteoporos Int. 2022;33.
    PubMed    



  46. IOF REGIONAL 2021 8th Asia Pacific Osteoporosis Conference: Symposium Abstract.
    Osteoporos Int. 2022;33.
    PubMed    



  47. IOF REGIONAL 2021 8th Asia Pacific Osteoporosis Conference: Speaker Abstracts.
    Osteoporos Int. 2022;33.
    PubMed    



  48. IOF REGIONAL 2021 8th Asia Pacific Osteoporosis Conference.
    Osteoporos Int. 2022;33.
    PubMed    


    March 2022
  49. LENTLE BC, Prior JC
    Osteoporotic vertebral fracture (OVF): diagnosis requires an informed observer.
    Osteoporos Int. 2022 Mar 30. pii: 10.1007/s00198-021-06287.
    PubMed    


  50. WANG YXJ
    Osteoporotic vertebral endplate and/or cortex fracture is not always radiographically detectable.
    Osteoporos Int. 2022 Mar 30. pii: 10.1007/s00198-021-06254.
    PubMed    


  51. XU WX, Wu W, Yang S, Chen T, et al
    Risk of osteoporosis and fracture after hysterectomies without oophorectomies: a systematic review and pooled analysis.
    Osteoporos Int. 2022 Mar 29. pii: 10.1007/s00198-022-06383.
    PubMed     Abstract available


  52. SCHOEB M, Winter EM, Malgo F, Schipper IB, et al
    Bone material strength index as measured by in vivo impact microindentation is normal in subjects with high-energy trauma fractures.
    Osteoporos Int. 2022 Mar 21. pii: 10.1007/s00198-022-06368.
    PubMed     Abstract available


  53. KAST S, Shojaa M, Kohl M, von Stengel S, et al
    Effects of different exercise intensity on bone mineral density in adults: a comparative systematic review and meta-analysis.
    Osteoporos Int. 2022 Mar 18. pii: 10.1007/s00198-022-06329.
    PubMed     Abstract available


  54. JAVAID MK, Harvey NC, McCloskey EV, Kanis JA, et al
    Assessment and management of imminent fracture risk in the setting of the fracture liaison service.
    Osteoporos Int. 2022 Mar 14. pii: 10.1007/s00198-021-06284.
    PubMed    


  55. HA J, Baek KH
    Correction to: Response to letter, re. "Comparison of fracture risk between type 1 and type 2 diabetes: a comprehensive real-world data".
    Osteoporos Int. 2022 Mar 11. pii: 10.1007/s00198-022-06373.
    PubMed    


  56. TUCK SP, Datta HK
    Letter of response to Professor Dalgleish regarding our paper Re: Long-term evaluation of anabolic and anti-resorptive agents in adults with familial osteoporosis due to pro205ala variant of the col1a1 gene.
    Osteoporos Int. 2022 Mar 2. pii: 10.1007/s00198-022-06332.
    PubMed    


  57. DALGLEISH R
    Re: Long-term evaluation of anabolic and anti-resorptive agents in adults with familial osteoporosis due to pro205ala variant of the col1a1 gene.
    Osteoporos Int. 2022 Mar 2. pii: 10.1007/s00198-022-06334.
    PubMed    


    February 2022
  58. SANCHEZ-TRIGO H, Rittweger J, Sanudo B
    Effects of non-supervised exercise interventions on bone mineral density in adult women: a systematic review and metaanalysis.
    Osteoporos Int. 2022 Feb 26. pii: 10.1007/s00198-022-06357.
    PubMed     Abstract available


  59. OKUDA R, Osaki M, Saeki Y, Okano T, et al
    Effect of coordinator-based osteoporosis intervention on quality of life in patients with fragility fractures: a prospective randomized trial.
    Osteoporos Int. 2022 Feb 23. pii: 10.1007/s00198-021-06279.
    PubMed     Abstract available


  60. BASTOUNIS A, Langley T, Davis S, Paskins Z, et al
    Comparing medication adherence in patients receiving bisphosphonates for preventing fragility fractures: a comprehensive systematic review and network meta-analysis.
    Osteoporos Int. 2022 Feb 21. pii: 10.1007/s00198-022-06350.
    PubMed     Abstract available


  61. OTHMAN M, Menon VK
    The prevalence of Schmorl's nodes in osteoporotic vs normal patients: a Middle Eastern population study.
    Osteoporos Int. 2022 Feb 17. pii: 10.1007/s00198-022-06316.
    PubMed     Abstract available


  62. LESLIE WD, Moller S, Skjodt MK, Yan L, et al
    FREM predicts 10-year incident fracture risk independent of FRAX(R) probability: a registry-based cohort study.
    Osteoporos Int. 2022 Feb 17. pii: 10.1007/s00198-022-06349.
    PubMed     Abstract available


  63. JEONGHOON H, Ki-Hyun B
    Response to letter, re. "Comparison of fracture risk between type 1 and type 2 diabetes: a comprehensive real-world data".
    Osteoporos Int. 2022 Feb 17. pii: 10.1007/s00198-022-06336.
    PubMed    


  64. GEBRE AK, Prince RL, Schousboe JT, Kiel DP, et al
    Calcaneal quantitative ultrasound is associated with all-cause and cardiovascular disease mortality independent of hip bone mineral density.
    Osteoporos Int. 2022 Feb 11. pii: 10.1007/s00198-022-06317.
    PubMed     Abstract available


  65. KHALID S, Calderon-Larranaga S, Sami A, Hawley S, et al
    Comparative risk of acute myocardial infarction for anti-osteoporosis drugs in primary care: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database.
    Osteoporos Int. 2022 Feb 9. pii: 10.1007/s00198-021-06262.
    PubMed     Abstract available


  66. FLEHR A, Kallgard J, Alven J, Lagerstrand K, et al
    Development of a novel method to measure bone marrow fat fraction in older women using high-resolution peripheral quantitative computed tomography.
    Osteoporos Int. 2022 Feb 3. pii: 10.1007/s00198-021-06224.
    PubMed     Abstract available


  67. GAGGIANO C, Bardelli M, Tarsia M, Gentileschi S, et al
    Neridronate for transient osteoporosis of the hip in a child.
    Osteoporos Int. 2022 Feb 1. pii: 10.1007/s00198-022-06324.
    PubMed     Abstract available


  68. ABDEL-HAMID MS, Elhossini RM, Otaify GA, Abdel-Ghafar SF, et al
    Osteoporosis-pseudoglioma syndrome in four new patients: identification of two novel LRP5 variants and insights on patients' management using bisphosphonates therapy.
    Osteoporos Int. 2022 Feb 1. pii: 10.1007/s00198-022-06313.
    PubMed     Abstract available


  69. CANOY D, Harvey NC, Prieto-Alhambra D, Cooper C, et al
    Elevated blood pressure, antihypertensive medications and bone health in the population: revisiting old hypotheses and exploring future research directions.
    Osteoporos Int. 2022;33:315-326.
    PubMed     Abstract available


    January 2022
  70. GOSSIEL F, Ugur A, Peel NFA, Walsh JS, et al
    The clinical utility of TRACP-5b to monitor anti-resorptive treatments of osteoporosis.
    Osteoporos Int. 2022 Jan 31. pii: 10.1007/s00198-022-06311.
    PubMed     Abstract available


  71. ASAHI R, Nakamura Y, Kanai M, Watanabe K, et al
    Association with sagittal alignment and osteoporosis-related fractures in outpatient women with osteoporosis.
    Osteoporos Int. 2022 Jan 29. pii: 10.1007/s00198-021-06282.
    PubMed     Abstract available


  72. BEAUDART C, Boonen A, Li N, Bours S, et al
    Patient preferences for lifestyle behaviours in osteoporotic fracture prevention: a cross-European discrete choice experiment.
    Osteoporos Int. 2022 Jan 26. pii: 10.1007/s00198-022-06310.
    PubMed     Abstract available


  73. STARUP-LINDE J, Langdahl B, Vestergaard P, Harslof T, et al
    Incident peptic ulcers and concomitant treatment of direct oral anticoagulants and oral bisphosphonates-a real-world cohort study.
    Osteoporos Int. 2022 Jan 26. pii: 10.1007/s00198-022-06315.
    PubMed     Abstract available


  74. GUPTA A, Cha T, Schwab J, Fogel H, et al
    Response to Assessing impacts of gender on adverse postoperative outcomes in patients undergoing osteoporotic vertebral compression fracture surgery.
    Osteoporos Int. 2022 Jan 21. pii: 10.1007/s00198-021-06243.
    PubMed    


  75. HONG FX, Xue FS, Hu B, Tian T, et al
    Assessing impacts of gender on adverse postoperative outcomes in patients undergoing osteoporotic vertebral compression fracture surgery.
    Osteoporos Int. 2022 Jan 21. pii: 10.1007/s00198-021-05992.
    PubMed    


  76. WAN Y, Zeng F, Tan H, Lu Y, et al
    Cost-effectiveness analyses of denosumab for osteoporosis: a systematic review.
    Osteoporos Int. 2022 Jan 21. pii: 10.1007/s00198-021-06268.
    PubMed     Abstract available


  77. TOMINAGA A, Wada K, Okazaki K, Nishi H, et al
    Effect of the duration of previous osteoporosis treatment on the effect of romosozumab treatment.
    Osteoporos Int. 2022 Jan 21. pii: 10.1007/s00198-021-06261.
    PubMed     Abstract available


  78. PINTO D, Alshahrani M, Chapurlat R, Chevalley T, et al
    The global approach to rehabilitation following an osteoporotic fragility fracture: A review of the rehabilitation working group of the International Osteoporosis Foundation (IOF) committee of scientific advisors.
    Osteoporos Int. 2022 Jan 20. pii: 10.1007/s00198-021-06240.
    PubMed     Abstract available


  79. SCHOUSBOE JT, Binkley N, Leslie WD
    Accurate estimation of vertebral fracture prevalence on lateral spine imaging requires use of validated ascertainment methods.
    Osteoporos Int. 2022 Jan 16. pii: 10.1007/s00198-021-06275.
    PubMed    


  80. LAI EC, Lin TC, Lange JL, Chen L, et al
    Effectiveness of denosumab for fracture prevention in real-world postmenopausal women with osteoporosis: a retrospective cohort study.
    Osteoporos Int. 2022 Jan 15. pii: 10.1007/s00198-021-06291.
    PubMed     Abstract available


  81. PATEL R, Shen J, Nichols JF, Schousboe JT, et al
    Trabecular bone score and its association with Cobb angle kyphosis in older men: a cross-sectional study for the Osteoporotic Fractures in Men (MrOS) Study.
    Osteoporos Int. 2022 Jan 15. pii: 10.1007/s00198-021-06267.
    PubMed     Abstract available


  82. KIMMEL DB, Vennin S, Desyatova A, Turner JA, et al
    Bone architecture, bone material properties, and bone turnover in non-osteoporotic post-menopausal women with fragility fracture.
    Osteoporos Int. 2022 Jan 15. pii: 10.1007/s00198-022-06308.
    PubMed     Abstract available


  83. STROM RONNQUIST S, Viberg B, Kristensen MT, Palm H, et al
    Frailty and osteoporosis in patients with hip fractures under the age of 60-a prospective cohort of 218 individuals.
    Osteoporos Int. 2022 Jan 14. pii: 10.1007/s00198-021-06281.
    PubMed     Abstract available


  84. IIDA H, Sakai Y, Seki T, Watanabe T, et al
    Bisphosphonate treatment is associated with decreased mortality rates in patients after osteoporotic vertebral fracture.
    Osteoporos Int. 2022 Jan 13. pii: 10.1007/s00198-021-06264.
    PubMed     Abstract available


  85. IKI M, Fujimori K, Nakatoh S, Tamaki J, et al
    Guideline adherence by physicians for management of glucocorticoid-induced osteoporosis in Japan: a nationwide health insurance claims database study.
    Osteoporos Int. 2022 Jan 13. pii: 10.1007/s00198-021-06265.
    PubMed     Abstract available


  86. LIANG YS, Yeh KC, Pan SL
    Osteoporosis and the long-term risk of peripheral artery disease: a population-based longitudinal follow-up study in Taiwan.
    Osteoporos Int. 2022 Jan 12. pii: 10.1007/s00198-022-06305.
    PubMed     Abstract available


  87. BERNARDES M, Monteiro R, Martins MJ
    Mineral-rich water consumption as a non-pharmacological intervention for early menopausal bone mineral density preservation and reduction of long-term fracture risk: comment on Billington et al. Osteoporos Int. 2021;32(7):1313-20.
    Osteoporos Int. 2022 Jan 12. pii: 10.1007/s00198-021-06272.
    PubMed    


  88. SHABANI F, Tsinaslanidis G, Thimmaiah R, Khatak M, et al
    Effect of institution volume on mortality and outcomes in osteoporotic hip fracture care.
    Osteoporos Int. 2022 Jan 8. pii: 10.1007/s00198-021-06249.
    PubMed     Abstract available


  89. CLAUSEN A, Moller S, Skjodt MK, Bech BH, et al
    Evaluating the performance of the Charlson Comorbidity Index (CCI) in fracture risk prediction and developing a new Charlson Fracture Index (CFI): a register-based cohort study.
    Osteoporos Int. 2022 Jan 6. pii: 10.1007/s00198-021-06293.
    PubMed     Abstract available


  90. SAAD RK, Ghezzawi M, Habli D, Alami RS, et al
    Fracture risk following bariatric surgery: a systematic review and meta-analysis.
    Osteoporos Int. 2022 Jan 5. pii: 10.1007/s00198-021-06206.
    PubMed     Abstract available


  91. BERMAN NK, Honig S, Cronstein BN, Pillinger MH, et al
    The effects of caffeine on bone mineral density and fracture risk.
    Osteoporos Int. 2022 Jan 4. pii: 10.1007/s00198-021-05972.
    PubMed     Abstract available


  92. DOCKERY F, Glynn A, Franks K, Carey JJ, et al
    Fracture liaison services in Ireland-how do we compare to international standards?
    Osteoporos Int. 2022 Jan 4. pii: 10.1007/s00198-021-06251.
    PubMed     Abstract available


  93. PARK SY, Kim J, Chung HY
    Denosumab-induced hypocalcemia in a patient with hyperthyroidism: a case report.
    Osteoporos Int. 2022;33:305-308.
    PubMed     Abstract available


    December 2021
  94. FAN Y, Ni S, Zhang H
    Association between Healthy Eating Index-2015 total and component food scores with osteoporosis in middle-aged and older Americans: a cross-sectional study with U.S. National Health and Nutrition Examination Survey.
    Osteoporos Int. 2021 Dec 2. pii: 10.1007/s00198-021-06247.
    PubMed     Abstract available


  95. NASSAR K, Janani S
    Diffuse adverse cutaneous reactions induced by zoledronic acid administration: a case report : Eruptions cutanees diffuses induites par l'administration de l'acide zoledronique.
    Osteoporos Int. 2021;32:2583-2586.
    PubMed     Abstract available


  96. BOCKER W, Doobaree IU, Khachatryan A, Dornstauder E, et al
    Correction to: Fractures in untreated patients with osteoporosis in Germany: an InGef healthcare insurance database analysis.
    Osteoporos Int. 2021 Dec 1. pii: 10.1007/s00198-021-06244.
    PubMed    


  97. CURTIN L, Conway MC, Kilbane MT, McKenna MJ, et al
    No effect of maternal calcium intake and bone resorption during pregnancy on offspring bone mineral density at age 5 years.
    Osteoporos Int. 2021 Dec 1. pii: 10.1007/s00198-021-06250.
    PubMed     Abstract available



  98. World Congress on Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Author Index.
    Osteoporos Int. 2021;32.
    PubMed    



  99. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Poster Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  100. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Satellite Sponsored Symposium Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  101. World Congress on Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Non-Sponsored Symposia Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  102. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Committee of Scientific Advisory Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  103. World congress on osteoporosis, osteoarthritis and musculoskeletal diseases (WCO-IOF-ESCEO 2021): Committee of National Societies Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  104. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Meet-The-Experts Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  105. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): ISGE-ESCEO Symposium Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  106. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): ROS-IOF-ESCEO Symposium Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  107. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): SICOT-ESCEO-IOF Symposium Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  108. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): EUGMS-ESCEO-IOF Symposium Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  109. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): ESPRM-ESCEO-IOF Symposium Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  110. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): ESCEO-WHO CC Symposium Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  111. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): ESCEO-IOF Symposium Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  112. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): ESCEO Symposium Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  113. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Oral Communication Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  114. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Plenary Lecture Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  115. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Educational Lectures Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  116. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Special Lecture Abstracts.
    Osteoporos Int. 2021;32.
    PubMed    



  117. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021).
    Osteoporos Int. 2021;32.
    PubMed    


    November 2021
  118. AGARWAL A, Leslie WD, Nguyen TV, Morin SN, et al
    Predictive performance of the Garvan Fracture Risk Calculator: a registry-based cohort study.
    Osteoporos Int. 2021 Nov 28. pii: 10.1007/s00198-021-06252.
    PubMed     Abstract available


  119. AGARWAL G, Milan C, Mohsin Z, Mahoney S, et al
    Multiple myeloma screening within a fracture liaison service (FLS).
    Osteoporos Int. 2021 Nov 26. pii: 10.1007/s00198-021-06233.
    PubMed     Abstract available


  120. HORII C, Iidaka T, Muraki S, Oka H, et al
    The cumulative incidence of and risk factors for morphometric severe vertebral fractures in Japanese men and women: the ROAD study third and fourth surveys.
    Osteoporos Int. 2021 Nov 19. pii: 10.1007/s00198-021-06143.
    PubMed     Abstract available


  121. KADRI A, Binkley N, Hernando D, Anderson PA, et al
    Opportunistic Use of Lumbar Magnetic Resonance Imaging for Osteoporosis Screening.
    Osteoporos Int. 2021 Nov 13. pii: 10.1007/s00198-021-06129.
    PubMed     Abstract available


  122. RUBAEK M, Hitz MF, Holmberg T, Schonwandt BMT, et al
    Effectiveness of patient education for patients with osteoporosis: a systematic review.
    Osteoporos Int. 2021 Nov 12. pii: 10.1007/s00198-021-06226.
    PubMed     Abstract available


  123. LIU Z, Zhang X, Liu H, Wang D, et al
    A nomogram for short-term recurrent pain after percutaneous vertebroplasty for osteoporotic vertebral compression fractures.
    Osteoporos Int. 2021 Nov 11. pii: 10.1007/s00198-021-06232.
    PubMed     Abstract available


  124. DEMINGER A, Klingberg E, Lorentzon M, Hedberg M, et al
    Correction to: Factors associated with changes in volumetric bone mineral density and cortical area in men with ankylosing spondylitis: a 5-year prospective study using HRpQCT.
    Osteoporos Int. 2021 Nov 2. pii: 10.1007/s00198-021-06156.
    PubMed    


    October 2021
  125. SAITO M, Moore-Lotridge SN, Uppuganti S, Egawa S, et al
    Determining the pharmacologic window of bisphosphonates that mitigates severe injury-induced osteoporosis and muscle calcification, while preserving fracture repair.
    Osteoporos Int. 2021 Oct 31. pii: 10.1007/s00198-021-06208.
    PubMed     Abstract available


  126. THARABENJASIN P, Pabalan N, Jarjanazi H, Jinawath N, et al
    Associations of osteoprotegerin (OPG) TNFRSF11B gene polymorphisms with risk of fractures in older adult populations: meta-analysis of genetic and genome-wide association studies.
    Osteoporos Int. 2021 Oct 30. pii: 10.1007/s00198-021-06161.
    PubMed     Abstract available


  127. ADAMS AL, Ryan DS, Li BH, Williams SA, et al
    Outcomes post fragility fracture among members of an integrated healthcare organization.
    Osteoporos Int. 2021 Oct 23. pii: 10.1007/s00198-021-06205.
    PubMed     Abstract available


  128. PRIOR JC, Oei EHG, Brown JP, Oei L, et al
    Where's the break? Critique of radiographic vertebral fracture diagnostic methods.
    Osteoporos Int. 2021 Oct 21. pii: 10.1007/s00198-021-06207.
    PubMed    


  129. CHEN T, Jiang R, Jiang L
    Comment on "Influence of glycemic control and hypoglycemia on the risk of fracture in patients with diabetes mellitus: a systematic review and meta-analysis of observational studies".
    Osteoporos Int. 2021 Oct 21. pii: 10.1007/s00198-021-06217.
    PubMed    


  130. ASPDEN RM
    RE: Advanced 2D image processing technique to predict hip fracture risk in an older population based on single DXA scans : F. Jazinizadeh, J.D. Adachi & C.E. Quenneville. Osteoporosis International volume 31, pages 1925-1933 (2020).
    Osteoporos Int. 2021 Oct 19. pii: 10.1007/s00198-021-06096.
    PubMed    


  131. GOETZ TG, Nair N, Shiau S, Recker RR, et al
    In premenopausal women with idiopathic osteoporosis, lower bone formation rate is associated with higher body fat and higher IGF-1.
    Osteoporos Int. 2021 Oct 19. pii: 10.1007/s00198-021-06196.
    PubMed     Abstract available


  132. JAZINIZADEH F, Adachi J, Quenneville C
    Response to Letter from Prof Aspen, re. "Advanced 2D image processing technique to predict hip fracture risk in an older population based on single DXA scans".
    Osteoporos Int. 2021 Oct 19. pii: 10.1007/s00198-021-06192.
    PubMed    


  133. SCHINI M, Peel N, Toronjo-Urquiza L, Thomas E, et al
    Evaluation of estimated glomerular function (eGFR) versus creatinine clearance (CrCl) to predict acute kidney injury when using zoledronate for the treatment of osteoporosis.
    Osteoporos Int. 2021 Oct 15. pii: 10.1007/s00198-021-06160.
    PubMed     Abstract available


  134. LOFFLER MT, Kallweit M, Niederreiter E, Baum T, et al
    Epidemiology and reporting of osteoporotic vertebral fractures in patients with long-term hospital records based on routine clinical CT imaging.
    Osteoporos Int. 2021 Oct 14. pii: 10.1007/s00198-021-06169.
    PubMed     Abstract available


  135. YAZDANPANAH Z, Beigrezaei S, Mohseni-Takalloo S, Soltani S, et al
    Does exercise affect bone mineral density and content when added to a calorie-restricted diet? A systematic review and meta-analysis of controlled clinical trials.
    Osteoporos Int. 2021 Oct 13. pii: 10.1007/s00198-021-06187.
    PubMed     Abstract available


  136. CHALITSIOS CV, Shaw DE, McKeever TM
    Risk of subtrochanteric and femoral shaft fractures due to bisphosphonate therapy in asthma: a population-based nested case-control study.
    Osteoporos Int. 2021 Oct 11. pii: 10.1007/s00198-021-06197.
    PubMed     Abstract available


  137. KUO DP, Chiu YW, Chen PT, Tsai YJ, et al
    Associations between body composition and vertebral fracture risk in postmenopausal women.
    Osteoporos Int. 2021 Oct 9. pii: 10.1007/s00198-021-06178.
    PubMed     Abstract available


  138. MUSCHITZ C, Hummer M, Grillari J, Hlava A, et al
    Epidemiology and economic burden of fragility fractures in Austria.
    Osteoporos Int. 2021 Oct 8. pii: 10.1007/s00198-021-06152.
    PubMed     Abstract available


  139. SAFIPOUR Z, van der Zanden R, van den Bergh J, Janssen P, et al
    The use of oral glucocorticoids and the risk of major osteoporotic fracture in patients with myasthenia gravis.
    Osteoporos Int. 2021 Oct 3. pii: 10.1007/s00198-021-06101.
    PubMed     Abstract available


  140. MOLLER S, Skjodt MK, Yan L, Abrahamsen B, et al
    Prediction of imminent fracture risk in Canadian women and men aged 45 years or older: external validation of the Fracture Risk Evaluation Model (FREM).
    Osteoporos Int. 2021 Oct 1. pii: 10.1007/s00198-021-06165.
    PubMed     Abstract available


    September 2021
  141. LESLIE WD, Yan L, Lix LM, Morin SN, et al
    Time dependency in early major osteoporotic and hip re-fractures in women and men aged 50 years and older: a population-based observational study.
    Osteoporos Int. 2021 Sep 25. pii: 10.1007/s00198-021-06166.
    PubMed     Abstract available


  142. BEAUDART C, Hiligsmann M, Li N, Lewiecki EM, et al
    Effective communication regarding risk of fracture for individuals at risk of fragility fracture: a scoping review.
    Osteoporos Int. 2021 Sep 24. pii: 10.1007/s00198-021-06151.
    PubMed     Abstract available


  143. GASSERT FT, Kufner A, Gassert FG, Leonhardt Y, et al
    MR-based proton density fat fraction (PDFF) of the vertebral bone marrow differentiates between patients with and without osteoporotic vertebral fractures.
    Osteoporos Int. 2021 Sep 18. pii: 10.1007/s00198-021-06147.
    PubMed     Abstract available


  144. WALTMAN N, Kupzyk KA, Flores LE, Mack LR, et al
    Bone-loading exercises versus risedronate for the prevention of osteoporosis in postmenopausal women with low bone mass: a randomized controlled trial.
    Osteoporos Int. 2021 Sep 14. pii: 10.1007/s00198-021-06083.
    PubMed     Abstract available


  145. GONG Z, Da W, Tian Y, Zhao R, et al
    Exogenous melatonin prevents type 1 diabetes mellitus-induced bone loss, probably by inhibiting senescence.
    Osteoporos Int. 2021 Sep 14. pii: 10.1007/s00198-021-06061.
    PubMed     Abstract available


  146. NAYAK S, Greenspan SL
    Cost-effectiveness of 3 versus 6 years of zoledronic acid treatment before bisphosphonate holiday for women with osteoporosis.
    Osteoporos Int. 2021 Sep 13. pii: 10.1007/s00198-021-06010.
    PubMed     Abstract available


  147. COLON-EMERIC CS, Lee RH
    Bisphosphonate holidays: using cost-effectiveness analysis for the "yes, but" questions.
    Osteoporos Int. 2021 Sep 13. pii: 10.1007/s00198-021-06064.
    PubMed    


  148. BLAKER K, Wijewardene A, White E, Stokes G, et al
    Electronic search programs are effective in identifying patients with minimal trauma fractures.
    Osteoporos Int. 2021 Sep 12. pii: 10.1007/s00198-021-06105.
    PubMed     Abstract available


  149. LIU J, Gong T, Xu X, Fox KM, et al
    Heavy clinical and economic burden of osteoporotic fracture among elderly female Medicare beneficiaries.
    Osteoporos Int. 2021 Sep 10. pii: 10.1007/s00198-021-06084.
    PubMed     Abstract available


  150. LARSSON BAM, Johansson L, Mellstrom D, Johansson H, et al
    One leg standing time predicts fracture risk in older women independent of clinical risk factors and BMD.
    Osteoporos Int. 2021 Sep 8. pii: 10.1007/s00198-021-06039.
    PubMed     Abstract available


  151. THOMASIUS F, Palacios S, Alam A, Boolell M, et al
    Fracture rates and economic outcomes in patients with osteoporosis prescribed risedronate gastro-resistant versus other oral bisphosphonates: a claims data analysis.
    Osteoporos Int. 2021 Sep 6. pii: 10.1007/s00198-021-06108.
    PubMed     Abstract available


  152. BLAND VL, Klimentidis YC, Bea JW, Roe DJ, et al
    Cross-sectional associations between adipose tissue depots and areal bone mineral density in the UK Biobank imaging study.
    Osteoporos Int. 2021 Sep 6. pii: 10.1007/s00198-021-06140.
    PubMed     Abstract available


  153. NIZNIK JD, Aspinall SL, Hanson LC, Gilliam MA, et al
    Patterns of oral bisphosphonate deprescribing in older nursing home residents with dementia.
    Osteoporos Int. 2021 Sep 4. pii: 10.1007/s00198-021-06141.
    PubMed     Abstract available


  154. PARK JH, Cho S, Kim SJ, Jeong TD, et al
    Serum biomarkers for bisphosphonate-related osteonecrosis of the jaw: a prospective clinical study.
    Osteoporos Int. 2021 Sep 2. pii: 10.1007/s00198-021-06137.
    PubMed     Abstract available


    August 2021
  155. VARENNA M, Crotti C, Bonati MT, Zucchi F, et al
    A novel mutation in collagen gene COL1A2 associated with transient regional osteoporosis.
    Osteoporos Int. 2021 Aug 31. pii: 10.1007/s00198-021-06135.
    PubMed     Abstract available


  156. HAGINO H, Sugimoto T, Tanaka S, Sasaki K, et al
    Correction to: A randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese osteoporosis intervention Trial-05.
    Osteoporos Int. 2021 Aug 27. pii: 10.1007/s00198-021-06066.
    PubMed    


  157. SU S, He N, Men P, Song C, et al
    Correction to: The efficacy and safety of menatetrenone in the management of osteoporosis: a systematic review and meta-analysis of randomized controlled trials.
    Osteoporos Int. 2021 Aug 27. pii: 10.1007/s00198-021-06053.
    PubMed    


  158. SINGH S, Dutta S, Khasbage S, Kumar T, et al
    A systematic review and meta-analysis of efficacy and safety of Romosozumab in postmenopausal osteoporosis.
    Osteoporos Int. 2021 Aug 25. pii: 10.1007/s00198-021-06095.
    PubMed     Abstract available


  159. BOSCHITSCH E, Naegele O, Klinger A, Brix-Samoylenko H, et al
    Long-term persistence with denosumab: real-world data from the Austrian Osteoporosis Clinic (AOC). A retrospective data analysis.
    Osteoporos Int. 2021 Aug 25. pii: 10.1007/s00198-021-06102.
    PubMed     Abstract available


  160. CHANDRAN M, Hao Y, Kwee AK, Cheen MHH, et al
    Adherence to dosing schedule of denosumab therapy for osteoporosis during COVID-19 lockdown: an electronic medical record and pharmacy claims database study from Asia.
    Osteoporos Int. 2021 Aug 21. pii: 10.1007/s00198-021-06085.
    PubMed     Abstract available


  161. SEAMAN AT, Steffen MJA, Van Tiem JM, Wardyn S, et al
    Cultivating across "pockets of excellence": challenges to sustaining efforts to improve osteoporosis care.
    Osteoporos Int. 2021 Aug 19. pii: 10.1007/s00198-021-06098.
    PubMed     Abstract available


  162. VENDRAMI C, Marques-Vidal P, Gonzalez Rodriguez E, Hans D, et al
    Thyroid-stimulating hormone is associated with trabecular bone score and 5-year incident fracture risk in euthyroid postmenopausal women: the OsteoLaus cohort.
    Osteoporos Int. 2021 Aug 19. pii: 10.1007/s00198-021-06081.
    PubMed     Abstract available


  163. ATMACA A, Demirci I, Haymana C, Tasci I, et al
    No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study.
    Osteoporos Int. 2021 Aug 17. pii: 10.1007/s00198-021-06067.
    PubMed     Abstract available


  164. KHALID S, Reyes C, Ernst M, Delmestri A, et al
    One- and 2-year incidence of osteoporotic fracture: a multi-cohort observational study using routinely collected real-world data.
    Osteoporos Int. 2021 Aug 15. pii: 10.1007/s00198-021-06077.
    PubMed     Abstract available


  165. ZHANG Y, Tian Z, Ye S, Mu Q, et al
    Changes in bone mineral density in Down syndrome individuals: a systematic review and meta-analysis.
    Osteoporos Int. 2021 Aug 12. pii: 10.1007/s00198-021-06070.
    PubMed     Abstract available


  166. BAJPAI RC
    Letter to the Editor about the article "C-reactive protein and fracture risk: an updated systematic review and meta-analysis of cohort studies through the use of both frequentist and Bayesian approaches".
    Osteoporos Int. 2021 Aug 12. pii: 10.1007/s00198-020-05750.
    PubMed    


  167. SCHEMITSCH E, Adachi JD, Brown JP, Tarride JE, et al
    Hip fracture predicts subsequent hip fracture: a retrospective observational study to support a call to early hip fracture prevention efforts in post-fracture patients.
    Osteoporos Int. 2021 Aug 11. pii: 10.1007/s00198-021-06080.
    PubMed     Abstract available


  168. SOLLING AS, Harslof T, Bruun NH, Langdahl B, et al
    The predictive value of bone turnover markers during discontinuation of alendronate: the PROSA study.
    Osteoporos Int. 2021;32:1557-1566.
    PubMed     Abstract available


    July 2021
  169. HA J, Jeong C, Han KD, Lim Y, et al
    Comparison of fracture risk between type 1 and type 2 diabetes: a comprehensive real-world data.
    Osteoporos Int. 2021 Jul 31. pii: 10.1007/s00198-021-06032.
    PubMed     Abstract available


  170. BOCKER W, Doobare IU, Khachatryan A, Dornstauder E, et al
    Fractures in untreated patients with osteoporosis in Germany: an InGef healthcare insurance database analysis.
    Osteoporos Int. 2021 Jul 15. pii: 10.1007/s00198-021-06051.
    PubMed     Abstract available


  171. ADAMI G, Cattani G, Rossini M, Viapiana O, et al
    Association between exposure to fine particulate matter and osteoporosis: a population-based cohort study.
    Osteoporos Int. 2021 Jul 15. pii: 10.1007/s00198-021-06060.
    PubMed     Abstract available


  172. IBRAHIMAGIC OC, Vujadinovic A, Ercegovic Z, Kunic S, et al
    Retraction Note to: Comment on an article: "Osteoporosis in the age of COVID-19 patients".
    Osteoporos Int. 2021 Jul 14. pii: 10.1007/s00198-021-06031.
    PubMed    


  173. DEMINGER A, Klingberg E, Lorentzon M, Hedberg M, et al
    Factors associated with changes in volumetric bone mineral density and cortical area in men with ankylosing spondylitis: a 5-year prospective study using HRpQCT.
    Osteoporos Int. 2021 Jul 14. pii: 10.1007/s00198-021-06049.
    PubMed     Abstract available


  174. TALEVSKI J, Sanders KM, Watts JJ, Nicholson GC, et al
    Sex differences in recovery of quality of life 12 months post-fracture in community-dwelling older adults: analyses of the Australian arm of the International Costs and Utilities Related to Osteoporotic Fractures Study (AusICUROS).
    Osteoporos Int. 2021 Jul 8. pii: 10.1007/s00198-021-06058.
    PubMed     Abstract available


  175. HAMED K, Roaldsen KS, Halvarsson A
    "Fear of falling serves as protection and signifies potential danger": a qualitative study to conceptualise the phrase "fear of falling" in women with osteoporosis.
    Osteoporos Int. 2021 Jul 7. pii: 10.1007/s00198-021-06047.
    PubMed     Abstract available


  176. SALE JEM, Yang A, Elliot-Gibson V, Jain R, et al
    Patients 80 + have similar medication initiation rates to those aged 50-79 in Ontario FLS.
    Osteoporos Int. 2021;32:1405-1411.
    PubMed     Abstract available


    June 2021
  177. MORIN SN, Yan L, Lix LM, Leslie WD, et al
    Long-term risk of subsequent major osteoporotic fracture and hip fracture in men and women: a population-based observational study with a 25-year follow-up.
    Osteoporos Int. 2021 Jun 24. pii: 10.1007/s00198-021-06028.
    PubMed     Abstract available


  178. ZHU M, Yin P, Hu F, Jiang J, et al
    Integrating genome-wide association and transcriptome prediction model identifies novel target genes for osteoporosis.
    Osteoporos Int. 2021 Jun 17. pii: 10.1007/s00198-021-06024.
    PubMed     Abstract available


  179. EVENEPOEL P, Cunningham J, Ferrari S, Haarhaus M, et al
    Diagnosis and management of osteoporosis in chronic kidney disease stages 4 to 5D: a call for a shift from nihilism to pragmatism.
    Osteoporos Int. 2021 Jun 15. pii: 10.1007/s00198-021-05975.
    PubMed     Abstract available


  180. SINGER AJ, Liu J, Yan H, Stad RK, et al
    Treatment patterns and long-term persistence with osteoporosis therapies in women with Medicare fee-for-service (FFS) coverage.
    Osteoporos Int. 2021 Jun 7. pii: 10.1007/s00198-021-05951.
    PubMed     Abstract available


    May 2021
  181. CHANDRAN M, Mitchell PJ, Amphansap T, Bhadada SK, et al
    Publisher Correction to: Development of the Asia Pacific Consortium on Osteoporosis (APCO) framework: clinical standards of care for the screening, diagnosis, and management of osteoporosis in the Asia-Pacific region.
    Osteoporos Int. 2021 May 27. pii: 10.1007/s00198-021-05953.
    PubMed    


  182. STUMPF U, Kraus M, Hadji P
    Influence of denosumab on bone mineral density in a severe case of pregnancy-associated osteoporosis.
    Osteoporos Int. 2021 May 26. pii: 10.1007/s00198-021-06008.
    PubMed     Abstract available


  183. IKI M, Winzenrieth R, Tamaki J, Sato Y, et al
    Predictive ability of novel volumetric and geometric indices derived from dual-energy X-ray absorptiometric images of the proximal femur for hip fracture compared with conventional areal bone mineral density: the Japanese Population-based Osteoporosis
    Osteoporos Int. 2021 May 26. pii: 10.1007/s00198-021-06013.
    PubMed     Abstract available


  184. PAL R, Bhadada SK, Mukherjee S, Banerjee M, et al
    Fracture risk in hypoparathyroidism: a systematic review and meta-analysis.
    Osteoporos Int. 2021 May 22. pii: 10.1007/s00198-021-05966.
    PubMed     Abstract available


  185. VAN DEN BERGH JP, Szulc P, Cheung AM, Bouxsein M, et al
    The clinical application of high-resolution peripheral computed tomography (HR-pQCT) in adults: state of the art and future directions.
    Osteoporos Int. 2021 May 22. pii: 10.1007/s00198-021-05999.
    PubMed     Abstract available


  186. CHEVALLEY T, Brandi ML, Cavalier E, Harvey NC, et al
    How can the orthopedic surgeon ensure optimal vitamin D status in patients operated for an osteoporotic fracture?
    Osteoporos Int. 2021 May 20. pii: 10.1007/s00198-021-05957.
    PubMed     Abstract available


  187. SVENSSON J, Ohlsson C, Karlsson MK, Lorentzon M, et al
    Subclinical hyperthyroidism is associated with increased risk of vertebral fractures in older men.
    Osteoporos Int. 2021 May 19. pii: 10.1007/s00198-021-05964.
    PubMed     Abstract available


  188. HAGINO H, Sugimoto T, Tanaka S, Sone T, et al
    A randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese Osteoporosis Intervention Trial-05.
    Osteoporos Int. 2021 May 17. pii: 10.1007/s00198-021-05996.
    PubMed     Abstract available


  189. CARDOZO B, Karatza E, Karalis V
    Osteoporosis treatment with risedronate: a population pharmacokinetic model for the description of its absorption and low plasma levels.
    Osteoporos Int. 2021 May 17. pii: 10.1007/s00198-021-05944.
    PubMed     Abstract available


  190. ANASTASILAKIS AD, Makras P, Doulgeraki A, Polyzos SA, et al
    Denosumab for the treatment of primary pediatric osteoporosis.
    Osteoporos Int. 2021 May 13. pii: 10.1007/s00198-021-06002.
    PubMed     Abstract available


  191. CHANG CB, Yang RS, Chang LY, Peng JK, et al
    One-year outcomes of an osteoporosis liaison services program initiated within a healthcare system.
    Osteoporos Int. 2021 May 6. pii: 10.1007/s00198-021-05859.
    PubMed     Abstract available


  192. LIU JJ, Fu SB, Jiang J, Tang XL, et al
    Association between outdoor particulate air pollution and the risk of osteoporosis: a systematic review and meta-analysis.
    Osteoporos Int. 2021 May 6. pii: 10.1007/s00198-021-05961.
    PubMed     Abstract available


  193. CASELLA M, Becciolini A, Di Donato E, Basaglia M, et al
    Internal medicine inpatients' prevalence of misdiagnosed severe osteoporosis.
    Osteoporos Int. 2021 May 5. pii: 10.1007/s00198-021-05976.
    PubMed     Abstract available


  194. JUNG YW, Hong N, Kim CO, Kim HC, et al
    The diagnostic value of phase angle, an integrative bioelectrical marker, for identifying individuals with dysmobility syndrome: the Korean Urban-Rural Elderly study.
    Osteoporos Int. 2021;32:939-949.
    PubMed     Abstract available


    April 2021
  195. SKIBICKI HE, Ponzio DY, Brustein JA, Post ZD, et al
    A cautionary case: osteoporotic femur fracture after robotic-assisted total knee arthroplasty.
    Osteoporos Int. 2021 Apr 30. pii: 10.1007/s00198-021-05977.
    PubMed     Abstract available


  196. YAMAMOTO Y, Chiba T, Dohmae S, Higashi K, et al
    Osteoporosis medication after fracture in older adults: an administrative data analysis.
    Osteoporos Int. 2021 Apr 29. pii: 10.1007/s00198-021-05973.
    PubMed    


  197. GU KD, Ettinger B, Grimsrud CD, Lo JC, et al
    Progression of atypical femur stress fracture after discontinuation of bisphosphonate therapy.
    Osteoporos Int. 2021 Apr 29. pii: 10.1007/s00198-021-05948.
    PubMed     Abstract available


  198. LYLES KW, Bauer DC, Colon-Emeric CS, Pieper CF, et al
    Zoledronic acid reduces the rate of clinical fractures after surgical repair of a hip fracture regardless of the Pretreatment bone mineral density.
    Osteoporos Int. 2021 Apr 27. pii: 10.1007/s00198-021-05923.
    PubMed     Abstract available


  199. KIM JT, Cha YH, Jeong S, Yoo JI, et al
    Subtrochanteric atypical femoral fracture induced solely by glucocorticoid without bisphosphonate treatment: a case report.
    Osteoporos Int. 2021 Apr 24. pii: 10.1007/s00198-021-05971.
    PubMed     Abstract available


  200. LIU ZM, Huang Q, Li SY, Liu YP, et al
    A 1:1 matched case-control study on dietary protein intakes and hip fracture risk in Chinese elderly men and women.
    Osteoporos Int. 2021 Apr 22. pii: 10.1007/s00198-021-05960.
    PubMed     Abstract available


  201. TENG Z, Zhu Y, Teng Y, Long Q, et al
    The analysis of osteosarcopenia as a risk factor for fractures, mortality, and falls.
    Osteoporos Int. 2021 Apr 20. pii: 10.1007/s00198-021-05963.
    PubMed     Abstract available


  202. HAUGER AV, Holvik K, Bergland A, Stahle A, et al
    Physical capability, physical activity, and their association with femoral bone mineral density in adults aged 40 years and older: The Tromso study 2015-2016.
    Osteoporos Int. 2021 Apr 16. pii: 10.1007/s00198-021-05949.
    PubMed     Abstract available


  203. HIDAYAT K, Fang QL, Shi BM, Qin LQ, et al
    Influence of glycemic control and hypoglycemia on the risk of fracture in patients with diabetes mellitus: a systematic review and meta-analysis of observational studies.
    Osteoporos Int. 2021 Apr 16. pii: 10.1007/s00198-021-05934.
    PubMed     Abstract available


  204. SI L, Eisman JA, Winzenberg T, Sanders KM, et al
    Development and validation of the risk engine for an Australian Health Economics Model of Osteoporosis.
    Osteoporos Int. 2021 Apr 15. pii: 10.1007/s00198-021-05955.
    PubMed     Abstract available


  205. BARAKE M, El Eid R, Ajjour S, Chakhtoura M, et al
    Osteoporotic hip and vertebral fractures in the Arab region: a systematic review.
    Osteoporos Int. 2021 Apr 7. pii: 10.1007/s00198-021-05937.
    PubMed     Abstract available


  206. DUSSAULT PM, McCarthy D, Davis SA, Thakore-James M, et al
    High prevalence of vertebral fractures in seizure patients with normal bone density receiving chronic anti-epileptic drugs.
    Osteoporos Int. 2021 Apr 6. pii: 10.1007/s00198-021-05926.
    PubMed     Abstract available


  207. PLUSKIEWICZ W, Adamczyk P, Drozdzowska B
    Height loss in postmenopausal women-do we need more for fracture risk assessment? Results from the GO Study.
    Osteoporos Int. 2021 Apr 5. pii: 10.1007/s00198-021-05941.
    PubMed     Abstract available


  208. KANIS JA, Johansson H, Harvey NC, Lorentzon M, et al
    An assessment of intervention thresholds for very high fracture risk applied to the NOGG guidelines : A report for the National Osteoporosis Guideline Group (NOGG).
    Osteoporos Int. 2021 Apr 4. pii: 10.1007/s00198-021-05942.
    PubMed     Abstract available


  209. DATTA HK, Vila J, Tuck SP
    Long-term evaluation of anabolic and anti-resorptive agents in adults with familial osteoporosis due to pro205ala variant of the col1a1 gene.
    Osteoporos Int. 2021 Apr 2. pii: 10.1007/s00198-021-05933.
    PubMed     Abstract available


  210. CHEN FP, Fu TS, Lin YC, Lin YJ, et al
    Addition of dexamethasone to manage acute phase responses following initial zoledronic acid infusion.
    Osteoporos Int. 2021;32:663-670.
    PubMed     Abstract available


    March 2021
  211. HAGINO H, Tanaka K, Silverman S, McClung M, et al
    Cost effectiveness of romosozumab versus teriparatide for severe postmenopausal osteoporosis in Japan.
    Osteoporos Int. 2021 Mar 27. pii: 10.1007/s00198-021-05927.
    PubMed     Abstract available


  212. TOMINAGA A, Wada K, Okazaki K, Nishi H, et al
    Early clinical effects, safety, and predictors of the effects of romosozumab treatment in osteoporosis patients: one-year study.
    Osteoporos Int. 2021 Mar 26. pii: 10.1007/s00198-021-05925.
    PubMed     Abstract available


  213. SKJODT MK, Ernst MT, Khalid S, Libanati C, et al
    The treatment gap after major osteoporotic fractures in Denmark 2005-2014: a combined analysis including both prescription-based and hospital-administered anti-osteoporosis medications.
    Osteoporos Int. 2021 Mar 15. pii: 10.1007/s00198-021-05890.
    PubMed     Abstract available


  214. FUGGLE NR, Singer A, Gill C, Patel A, et al
    Correction to: How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey.
    Osteoporos Int. 2021 Mar 9. pii: 10.1007/s00198-021-05905.
    PubMed    


  215. GIRGIS CM, Clifton-Bligh RJ
    Reply to Comment on "Osteoporosis in the Age of COVID-19".
    Osteoporos Int. 2021 Mar 4. pii: 10.1007/s00198-021-05901.
    PubMed    


  216. BARTOSCH P, Malmgren L, Kristensson J, McGuigan FE, et al
    In community-dwelling women frailty is associated with imminent risk of osteoporotic fractures.
    Osteoporos Int. 2021 Mar 4. pii: 10.1007/s00198-021-05886.
    PubMed     Abstract available


  217. BARZILAY JI, Buzkova P, Djousse L, Ix J, et al
    Serum non-esterified fatty acid levels and hip fracture risk: The Cardiovascular Health Study.
    Osteoporos Int. 2021 Mar 2. pii: 10.1007/s00198-021-05897.
    PubMed     Abstract available


  218. WINZENRIETH R, Ominsky MS, Wang Y, Humbert L, et al
    Differential effects of abaloparatide and teriparatide on hip cortical volumetric BMD by DXA-based 3D modeling.
    Osteoporos Int. 2021;32:575-583.
    PubMed     Abstract available


  219. ZULLO AR, Lee Y, Lary C, Daiello LA, et al
    Comparative effectiveness of denosumab, teriparatide, and zoledronic acid among frail older adults: a retrospective cohort study.
    Osteoporos Int. 2021;32:565-573.
    PubMed     Abstract available


    February 2021
  220. GAO L, Jiao T, Feng Q, Wang W, et al
    Application of artificial intelligence in diagnosis of osteoporosis using medical images: a systematic review and meta-analysis.
    Osteoporos Int. 2021 Feb 27. pii: 10.1007/s00198-021-05887.
    PubMed     Abstract available


  221. CHOI YJ, Shin HB, Park B, Kim DJ, et al
    Temporal change in the diagnosis and treatment rates of osteoporosis: results from the Korea National Health and Nutrition Examination Survey.
    Osteoporos Int. 2021 Feb 25. pii: 10.1007/s00198-021-05864.
    PubMed     Abstract available



  222. Correction to: Over half of seniors who start oral bisphosphonate therapy are exposed for 3 or more years: novel rolling window approach and patterns of use.
    Osteoporos Int. 2021 Feb 24. pii: 10.1007/s00198-021-05883.
    PubMed    


  223. BERGMAN J, Nordstrom A, Hommel A, Kivipelto M, et al
    Correction to: Bisphosphonates and mortality: confounding in observational studies.
    Osteoporos Int. 2021 Feb 19. pii: 10.1007/s00198-021-05884.
    PubMed    


  224. SAAG K, Cosman F, De Villiers T, Langdahl B, et al
    Early changes in bone turnover and bone mineral density after discontinuation of long-term oral bisphosphonates: a post hoc analysis.
    Osteoporos Int. 2021 Feb 19. pii: 10.1007/s00198-020-05785.
    PubMed     Abstract available


  225. HUANG X, Chen B, Thabane L, Adachi JD, et al
    Fragility of results from randomized controlled trials supporting the guidelines for the treatment of osteoporosis: a retrospective analysis.
    Osteoporos Int. 2021 Feb 17. pii: 10.1007/s00198-021-05865.
    PubMed     Abstract available


  226. YANG BR, Cha SH, Lee KE, Kim JW, et al
    Effect of dipeptidyl peptidase IV inhibitors, thiazolidinedione, and sulfonylurea on osteoporosis in patients with type 2 diabetes: population-based cohort study.
    Osteoporos Int. 2021 Feb 16. pii: 10.1007/s00198-020-05801.
    PubMed     Abstract available


  227. DRIESSEN JHM, van Dort MJ, Romme EAPM, Wouters EFM, et al
    Associations between bone attenuation and prevalent vertebral fractures on chest CT scans differ with vertebral fracture locations.
    Osteoporos Int. 2021 Feb 16. pii: 10.1007/s00198-020-05719.
    PubMed     Abstract available


  228. DELSMANN MM, Strahl A, Muhlenfeld M, Jandl NM, et al
    High prevalence and undertreatment of osteoporosis in elderly patients undergoing total hip arthroplasty.
    Osteoporos Int. 2021 Feb 11. pii: 10.1007/s00198-021-05881.
    PubMed     Abstract available


  229. HSU HE, Hsu YP, Yu CH
    Multiple vertebral compression fractures in a human immunodeficiency virus-positive patient with glucocorticoid-induced Cushing syndrome treated with percutaneous vertebroplasty: a case report.
    Osteoporos Int. 2021 Feb 11. pii: 10.1007/s00198-021-05880.
    PubMed     Abstract available


  230. ERWIN J, Enki DG, Woolf AD
    Younger people with rheumatoid arthritis are at increased risk of fracture even before age 50 years: a population-based cohort study.
    Osteoporos Int. 2021 Feb 11. pii: 10.1007/s00198-021-05862.
    PubMed     Abstract available


  231. MICHALSKI AS, Besler BA, Burt LA, Boyd SK, et al
    Opportunistic CT screening predicts individuals at risk of major osteoporotic fracture.
    Osteoporos Int. 2021 Feb 10. pii: 10.1007/s00198-021-05863.
    PubMed     Abstract available


  232. EASTMAN K, Gerlach M, Piec I, Greeves J, et al
    Effectiveness of parathyroid hormone (PTH) analogues on fracture healing: a meta-analysis.
    Osteoporos Int. 2021 Feb 9. pii: 10.1007/s00198-021-05847.
    PubMed     Abstract available


  233. SINGER AJ, Fuggle NR, Gill CB, Patel AR, et al
    COVID-19 and effects on osteoporosis management: the patient perspective from a National Osteoporosis Foundation survey.
    Osteoporos Int. 2021 Feb 8. pii: 10.1007/s00198-021-05836.
    PubMed    


  234. FUGGLE NR, Singer A, Gill C, Patel A, et al
    How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey.
    Osteoporos Int. 2021 Feb 8. pii: 10.1007/s00198-020-05793.
    PubMed     Abstract available


  235. CONSTABLE AM, Vlachopoulos D, Barker AR, Moore SA, et al
    The independent and interactive associations of physical activity intensity and vitamin D status with bone mineral density in prepubertal children: the PANIC Study.
    Osteoporos Int. 2021 Feb 5. pii: 10.1007/s00198-021-05872.
    PubMed     Abstract available


  236. KANIS JA, Johansson H, Harvey NC, Gudnason V, et al
    The effect on subsequent fracture risk of age, sex, and prior fracture site by recency of prior fracture.
    Osteoporos Int. 2021 Feb 4. pii: 10.1007/s00198-020-05803.
    PubMed     Abstract available


  237. MCCLOSKEY EV, Johansson H, Harvey NC, Lorentzon M, et al
    Romosozumab efficacy on fracture outcomes is greater in patients at high baseline fracture risk: a post hoc analysis of the first year of the frame study.
    Osteoporos Int. 2021 Feb 3. pii: 10.1007/s00198-020-05815.
    PubMed     Abstract available


  238. ROBIN F, Cadiou S, Albert JD, Bart G, et al
    Methotrexate osteopathy: five cases and systematic literature review.
    Osteoporos Int. 2021;32:225-232.
    PubMed     Abstract available


    January 2021
  239. PLUSKIEWICZ W, Wilk R, Adamczyk P, Hajzyk M, et al
    The incidence of arm, forearm, and hip osteoporotic fractures during early stage of COVID-19 pandemic.
    Osteoporos Int. 2021 Jan 30. pii: 10.1007/s00198-020-05811.
    PubMed     Abstract available


  240. FRANCIOTTI R, Moharrami M, Quaranta A, Bizzoca ME, et al
    Use of fractal analysis in dental images for osteoporosis detection: a systematic review and meta-analysis.
    Osteoporos Int. 2021 Jan 28. pii: 10.1007/s00198-021-05852.
    PubMed     Abstract available


  241. CHANDRAN M, Mitchell PJ, Amphansap T, Bhadada SK, et al
    Development of the Asia Pacific Consortium on Osteoporosis (APCO) Framework: clinical standards of care for the screening, diagnosis, and management of osteoporosis in the Asia-Pacific region.
    Osteoporos Int. 2021 Jan 27. pii: 10.1007/s00198-020-05742.
    PubMed     Abstract available


  242. CRAWFORD-MANNING F, Greenall C, Hawarden A, Bullock L, et al
    Evaluation of quality and readability of online patient information on osteoporosis and osteoporosis drug treatment and recommendations for improvement.
    Osteoporos Int. 2021 Jan 27. pii: 10.1007/s00198-020-05800.
    PubMed     Abstract available


  243. PAUL J, Devarapalli V, Johnson JT, Cherian KE, et al
    Do proximal hip geometry, trabecular microarchitecture, and prevalent vertebral fractures differ in postmenopausal women with type 2 diabetes mellitus? A cross-sectional study from a teaching hospital in southern India.
    Osteoporos Int. 2021 Jan 27. pii: 10.1007/s00198-021-05855.
    PubMed     Abstract available


  244. SAHOTA O, van Berkel D, Ong T, Drummond A, et al
    Pelvic fragility fractures-the forgotten osteoporotic fracture!
    Osteoporos Int. 2021 Jan 25. pii: 10.1007/s00198-021-05848.
    PubMed    


  245. OSAKI M, Okuda R, Saeki Y, Okano T, et al
    Efficiency of coordinator-based osteoporosis intervention in fragility fracture patients: a prospective randomized trial.
    Osteoporos Int. 2021 Jan 23. pii: 10.1007/s00198-021-05825.
    PubMed     Abstract available


  246. IBRAHIMAGIC OC, Vujadinovic A, Ercegovic Z, Kunic S, et al
    Comment on an article: "Osteoporosis in the age of COVID-19 patients".
    Osteoporos Int. 2021 Jan 21. pii: 10.1007/s00198-020-05607.
    PubMed    


  247. HOFF M, Skovlund E, Meyer HE, Langhammer A, et al
    Does treatment with bisphosphonates protect against fractures in real life? The HUNT study, Norway.
    Osteoporos Int. 2021 Jan 21. pii: 10.1007/s00198-021-05845.
    PubMed     Abstract available


  248. LEMS WF, Paccou J, Zhang J, Fuggle NR, et al
    Vertebral fracture: epidemiology, impact and use of DXA vertebral fracture assessment in fracture liaison services.
    Osteoporos Int. 2021 Jan 21. pii: 10.1007/s00198-020-05804.
    PubMed     Abstract available


  249. GOU P, Wang Z, Zhao Z, Wang Y, et al
    Restoration of the intravertebral stability in Kummell's disease following the treatment of severe postmenopausal osteoporosis by 1-34PTH-a retrospective study.
    Osteoporos Int. 2021 Jan 20. pii: 10.1007/s00198-020-05761.
    PubMed     Abstract available


  250. WANDELL P, Li X, Carlsson AC, Sundquist J, et al
    Osteoporotic fractures in second-generation immigrants and Swedish natives.
    Osteoporos Int. 2021 Jan 19. pii: 10.1007/s00198-020-05776.
    PubMed     Abstract available


  251. LUCASSEN MJJ, Ter Wee MM, den Uyl D, Konijn NPC, et al
    Long-term effects on bone mineral density after four years of treatment with two intensive combination strategies, including initially high-dose prednisolone, in early rheumatoid arthritis patients: the COBRA-light trial.
    Osteoporos Int. 2021 Jan 19. pii: 10.1007/s00198-020-05781.
    PubMed     Abstract available


  252. LU K, Yin Y, Li C, Jin Y, et al
    Efficacy of annual zoledronic acid in initial percutaneous kyphoplasty patients with osteoporotic vertebral compression fractures: a 3-year follow-up study.
    Osteoporos Int. 2021 Jan 18. pii: 10.1007/s00198-020-05816.
    PubMed     Abstract available


  253. LIU CS, Feasel AL, Kline GA, Billington EO, et al
    Pharmacotherapy decisions among postmenopausal women attending a group medical consultation or a one-on-one specialist consultation at an osteoporosis center: an observational cohort study.
    Osteoporos Int. 2021 Jan 18. pii: 10.1007/s00198-021-05823.
    PubMed     Abstract available


  254. GUANABENS N, Olmos JM, Hernandez JL, Cerda D, et al
    Vertebral fractures are increased in rheumatoid arthritis despite recent therapeutic advances: a case-control study.
    Osteoporos Int. 2021 Jan 18. pii: 10.1007/s00198-021-05824.
    PubMed     Abstract available


  255. POWELL J, Michael A
    Peri-operative derangement in liver function tests in older patients with neck of femur fracture.
    Osteoporos Int. 2021 Jan 18. pii: 10.1007/s00198-021-05827.
    PubMed     Abstract available


  256. HILIGSMANN M, Maggi S, Veronese N, Sartori L, et al
    Cost-effectiveness of buffered soluble alendronate 70 mg effervescent tablet for the treatment of postmenopausal women with osteoporosis in Italy.
    Osteoporos Int. 2021 Jan 14. pii: 10.1007/s00198-020-05802.
    PubMed     Abstract available


  257. WU YF, Lu K, Girgis C, Preda M, et al
    Postpartum bilateral sacral stress fracture without osteoporosis-a case report and literature review.
    Osteoporos Int. 2021 Jan 13. pii: 10.1007/s00198-020-05788.
    PubMed     Abstract available


  258. XU F, Zhang Q, Wang LK, Tang QX, et al
    Estimates of the effects of physical activity on osteoporosis using multivariable Mendelian randomization analysis.
    Osteoporos Int. 2021 Jan 13. pii: 10.1007/s00198-020-05786.
    PubMed     Abstract available


  259. BILLINGTON EO, Leslie WD, Brown JP, Prior JC, et al
    Simulated effects of early menopausal bone mineral density preservation on long-term fracture risk: a feasibility study.
    Osteoporos Int. 2021 Jan 12. pii: 10.1007/s00198-021-05826.
    PubMed     Abstract available


  260. DE VRIES BCS, Hegeman JH, Nijmeijer W, Geerdink J, et al
    Comparing three machine learning approaches to design a risk assessment tool for future fractures: predicting a subsequent major osteoporotic fracture in fracture patients with osteopenia and osteoporosis.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05735.
    PubMed     Abstract available


  261. XU X, Zhang M, Fei Z, Sheng H, et al
    Calcification of lower extremity arteries is related to the presence of osteoporosis in postmenopausal women with type 2 diabetes mellitus: a cross-sectional observational study.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05775.
    PubMed     Abstract available


  262. TRAN O, Silverman S, Xu X, Bonafede M, et al
    Long-term direct and indirect economic burden associated with osteoporotic fracture in US postmenopausal women.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05769.
    PubMed     Abstract available


  263. SORESKOG E, Borgstrom F, Lindberg I, Strom O, et al
    A novel economic framework to assess the cost-effectiveness of bone-forming agents in the prevention of fractures in patients with osteoporosis.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05765.
    PubMed     Abstract available


  264. HANS D, Shevroja E, Leslie WD
    Evolution in fracture risk assessment: artificial versus augmented intelligence.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05737.
    PubMed    


  265. YU WY, Hwang HF, Chen CY, Lin MR, et al
    Situational risk factors for fall-related vertebral fractures in older men and women.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05799.
    PubMed     Abstract available


  266. HAYES KN, He N, Brown KA, Cheung AM, et al
    Over half of seniors who start oral bisphosphonate therapy are exposed for 3 or more years: novel rolling window approach and patterns of use.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05794.
    PubMed     Abstract available


  267. ZHANG Z, Zhou X, Shu L, Hu M, et al
    The association between overweight/obesity and vertebral fractures in older adults: a meta-analysis of observational studies.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05764.
    PubMed     Abstract available


  268. ICONARU L, Moreau M, Baleanu F, Kinnard V, et al
    Risk factors for imminent fractures: a substudy of the FRISBEE cohort.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05772.
    PubMed     Abstract available


  269. SOLLING AS, Christensen DH, Darvalics B, Harslof T, et al
    Fracture rates in patients discontinuing alendronate treatment in real life: a population-based cohort study.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05745.
    PubMed     Abstract available


  270. SORESKOG E, Lindberg I, Kanis JA, Akesson KE, et al
    Cost-effectiveness of romosozumab for the treatment of postmenopausal women with severe osteoporosis at high risk of fracture in Sweden.
    Osteoporos Int. 2021 Jan 6. pii: 10.1007/s00198-020-05780.
    PubMed     Abstract available


  271. ZHOU H, Li C, Song W, Wei M, et al
    Increasing fasting glucose and fasting insulin associated with elevated bone mineral density-evidence from cross-sectional and MR studies.
    Osteoporos Int. 2021 Jan 6. pii: 10.1007/s00198-020-05762.
    PubMed     Abstract available


  272. ZHU Q, Xu J, Zhou M, Lian X, et al
    Association between type 1 diabetes mellitus and reduced bone mineral density in children: a meta-analysis.
    Osteoporos Int. 2021 Jan 6. pii: 10.1007/s00198-020-05715.
    PubMed     Abstract available


  273. WU Y, Wang F, Zhang Z
    The efficacy and safety of bisphosphonate analogs for treatment of osteoporosis after spinal cord injury: a systematic review and meta-analysis of randomized controlled trials.
    Osteoporos Int. 2021 Jan 2. pii: 10.1007/s00198-020-05807.
    PubMed     Abstract available


  274. SAPKOTA HR, Nune A, Bateman J, Venkatachalam S, et al
    A pragmatic proposal for triaging DXA testing during the COVID-19 global pandemic.
    Osteoporos Int. 2021;32:1-6.
    PubMed     Abstract available


    December 2020
  275. KRISTJANSDOTTIR HL, Mellstrom D, Johansson P, Karlsson M, et al
    High platelet count is associated with low bone mineral density: The MrOS Sweden cohort.
    Osteoporos Int. 2020 Dec 11. pii: 10.1007/s00198-020-05766.
    PubMed     Abstract available


  276. BURDEN AM, Tanaka Y, Xu L, Ha YC, et al
    Osteoporosis case ascertainment strategies in European and Asian countries: a comparative review.
    Osteoporos Int. 2020 Dec 10. pii: 10.1007/s00198-020-05756.
    PubMed     Abstract available



  277. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Author Index.
    Osteoporos Int. 2020;31.
    PubMed    



  278. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Satellite Symposia Abstracts.
    Osteoporos Int. 2020;31.
    PubMed    



  279. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Poster Abstracts.
    Osteoporos Int. 2020;31.
    PubMed    



  280. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Non-Sponsored Symposia Abstracts.
    Osteoporos Int. 2020;31.
    PubMed    



  281. World congress on osteoporosis, osteoarthritis and musculoskeletal diseases (WCO-IOF-ESCEO 2020): Committee of Scientific Advisors Abstracts.
    Osteoporos Int. 2020;31.
    PubMed    



  282. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Committee of National Societies Abstracts.
    Osteoporos Int. 2020;31.
    PubMed    



  283. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Meet-The-Experts Abstracts.
    Osteoporos Int. 2020;31.
    PubMed    



  284. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): ESPRM-ESCEO-IOF Symposium Abstracts.
    Osteoporos Int. 2020;31.
    PubMed    



  285. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): EUGMS-ESCEO-IOF Symposium Abstracts.
    Osteoporos Int. 2020;31.
    PubMed    



  286. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): ESCEO-WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging Symposium Abstracts (ESCEO-WHOCC).
    Osteoporos Int. 2020;31.
    PubMed    



  287. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): ESCEO-IOF Symposia Abstracts.
    Osteoporos Int. 2020;31.
    PubMed    



  288. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): ESCEO Symposium Abstracts.
    Osteoporos Int. 2020;31.
    PubMed    



  289. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Oral Communications Abstracts.
    Osteoporos Int. 2020;31.
    PubMed    



  290. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Plenary Lectures Abstracts.
    Osteoporos Int. 2020;31.
    PubMed    



  291. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Educational Lecture Abstracts.
    Osteoporos Int. 2020;31.
    PubMed    



  292. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Special Lecture Abstract.
    Osteoporos Int. 2020;31.
    PubMed    



  293. WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.
    Osteoporos Int. 2020;31.
    PubMed    


  294. CAMPONOVO C, Aubry-Rozier B, Lamy O, Gonzalez Rodriguez E, et al
    Hypercalcemia upon denosumab withdrawal in primary hyperparathyroidism: a case report and literature review.
    Osteoporos Int. 2020;31:2485-2491.
    PubMed     Abstract available


  295. ABDALA R, Levi L, Longobardi V, Zanchetta MB, et al
    Severe bone microarchitecture deterioration in a family with hereditary neuropathy: evidence of the key role of the mechanostat.
    Osteoporos Int. 2020;31:2477-2480.
    PubMed     Abstract available


  296. IMEL EA, Starzyk K, Gliklich R, Weiss RJ, et al
    Characterizing patients initiating abaloparatide, teriparatide, or denosumab in a real-world setting: a US linked claims and EMR database analysis.
    Osteoporos Int. 2020;31:2413-2424.
    PubMed     Abstract available


    November 2020
  297. DAHL C, Madsen C, Omsland TK, Sogaard AJ, et al
    Contribution of elevation and residential proximity to the coast in explaining geographic variations in hip fracture incidence. A Norwegian Epidemiologic Osteoporosis Studies (NOREPOS) study.
    Osteoporos Int. 2020 Nov 27. pii: 10.1007/s00198-020-05736.
    PubMed     Abstract available


  298. OZAKI D, Kubota R, Maeno T, Abdelhakim M, et al
    Association between gut microbiota, bone metabolism, and fracture risk in postmenopausal Japanese women.
    Osteoporos Int. 2020 Nov 25. pii: 10.1007/s00198-020-05728.
    PubMed     Abstract available


  299. NING HT, Du Y, Zhao LJ, Tian Q, et al
    Racial and gender differences in the relationship between sarcopenia and bone mineral density among older adults.
    Osteoporos Int. 2020 Nov 24. pii: 10.1007/s00198-020-05744.
    PubMed     Abstract available


  300. LANE NE, Saag K, O'Neill TJ, Manion M, et al
    Real-world bone turnover marker use: impact on treatment decisions and fracture.
    Osteoporos Int. 2020 Nov 24. pii: 10.1007/s00198-020-05734.
    PubMed     Abstract available


  301. MIN C, Yoo DM, Wee JH, Lee HJ, et al
    High-Intensity Physical Activity with High Serum Vitamin D Levels is Associated with a Low Prevalence of Osteopenia and Osteoporosis: A Population-Based Study.
    Osteoporos Int. 2020 Nov 23. pii: 10.1007/s00198-020-05746.
    PubMed     Abstract available


  302. BINKLEY N, Orwoll E, Chapurlat R, Langdahl BL, et al
    Randomized, controlled trial to assess the safety and efficacy of odanacatib in the treatment of men with osteoporosis.
    Osteoporos Int. 2020 Nov 17. pii: 10.1007/s00198-020-05701.
    PubMed     Abstract available


  303. ONG T, Copeland R, Thiam CN, Cerda Mas G, et al
    Integration of a vertebral fracture identification service into a fracture liaison service: a quality improvement project.
    Osteoporos Int. 2020 Nov 10. pii: 10.1007/s00198-020-05710.
    PubMed     Abstract available


  304. TANG C, Zhang W, Li H, Li L, et al
    CNN-based qualitative detection of bone mineral density via diagnostic CT slices for osteoporosis screening.
    Osteoporos Int. 2020 Nov 9. pii: 10.1007/s00198-020-05673.
    PubMed     Abstract available


  305. NG CA, McMillan LB, Humbert L, Ebeling PR, et al
    Feasibility, safety and effectiveness of a pilot 16-week home-based, impact exercise intervention in postmenopausal women with low bone mineral density.
    Osteoporos Int. 2020 Nov 7. pii: 10.1007/s00198-020-05723.
    PubMed     Abstract available


  306. KANIS JA, Harvey NC, Lorentzon M, Liu E, et al
    Combining fracture outcomes in phase 3 trials of osteoporosis: an analysis of the effects of denosumab in postmenopausal women.
    Osteoporos Int. 2020 Nov 6. pii: 10.1007/s00198-020-05699.
    PubMed     Abstract available


  307. LEE JW, Min C, Bang CH, Kwon BC, et al
    Psoriasis is associated with an increased risk of osteoporosis: follow-up and nested case-control studies using a national sample cohort.
    Osteoporos Int. 2020 Nov 5. pii: 10.1007/s00198-020-05724.
    PubMed     Abstract available


  308. KANIS JA, Cooper C, Dawson-Hughes B, Harvey NC, et al
    FRAX and ethnicity.
    Osteoporos Int. 2020;31:2063-2067.
    PubMed    


    October 2020
  309. RANGANATH LR, Khedr M, Vinjamuri S, Gallagher JA, et al
    Frequency, diagnosis, pathogenesis and management of osteoporosis in alkaptonuria: data analysis from the UK National Alkaptonuria Centre.
    Osteoporos Int. 2020 Oct 29. pii: 10.1007/s00198-020-05671.
    PubMed     Abstract available


  310. RIKKONEN T, Sund R, Sirola J, Honkanen R, et al
    Obesity is associated with early hip fracture risk in postmenopausal women: a 25-year follow-up.
    Osteoporos Int. 2020 Oct 23. pii: 10.1007/s00198-020-05665.
    PubMed     Abstract available


  311. LARSSON BAM, Johansson L, Johansson H, Axelsson KF, et al
    The timed up and go test predicts fracture risk in older women independently of clinical risk factors and bone mineral density.
    Osteoporos Int. 2020 Oct 21. pii: 10.1007/s00198-020-05681.
    PubMed     Abstract available


  312. KANIS JA, Johansson H, Harvey NC, Gudnason V, et al
    The use of 2-, 5-, and 10-year probabilities to characterize fracture risk after a recent sentinel fracture.
    Osteoporos Int. 2020 Oct 20. pii: 10.1007/s00198-020-05700.
    PubMed     Abstract available


  313. ASANO Y, Tajiri K, Yagishita S, Nakanishi H, et al
    Correction to: Bilateral atypical ulnar fractures occurring after long-term treatment with bisphosphonate for 7 years and with teriparatide for 2 years: a case report.
    Osteoporos Int. 2020 Oct 20. pii: 10.1007/s00198-020-05679.
    PubMed     Abstract available


  314. MCCLOSKEY EV, Harvey NC, Johansson H, Lorentzon M, et al
    Global impact of COVID-19 on non-communicable disease management: descriptive analysis of access to FRAX fracture risk online tool for prevention of osteoporotic fractures.
    Osteoporos Int. 2020 Oct 14. pii: 10.1007/s00198-020-05542.
    PubMed     Abstract available


  315. LAROCHE M, Champs B, Couture G, Degboe Y, et al
    Consequence of vertebral fracture cascades: about a cohort of 79 patients.
    Osteoporos Int. 2020 Oct 14. pii: 10.1007/s00198-020-05581.
    PubMed    


  316. DOMICIANO DS, Machado LG, Figueiredo CP, Caparbo VF, et al
    Incidence and risk factors for osteoporotic non-vertebral fracture in low-income community-dwelling elderly: a population-based prospective cohort study in Brazil. The Sao Paulo Ageing and Health (SPAH) study.
    Osteoporos Int. 2020 Oct 10. pii: 10.1007/s00198-020-05669.
    PubMed     Abstract available


  317. RONN SH, Harslof T, Oei L, Pedersen SB, et al
    The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia, a 3-year randomized, placebo-controlled clinical trial.
    Osteoporos Int. 2020 Oct 8. pii: 10.1007/s00198-020-05638.
    PubMed     Abstract available


  318. CUNDY T
    Treat-to-target-mainstream or marketing?
    Osteoporos Int. 2020;31:1835-1836.
    PubMed    


    September 2020
  319. ZHU K, Zhang J, Zhang C, Zhao Z, et al
    Therapeutic efficacy of zoledronic acid combined with calcitriol in elderly patients receiving total hip arthroplasty or hemiarthroplasty for osteoporotic femoral neck fracture.
    Osteoporos Int. 2020 Sep 28. pii: 10.1007/s00198-020-05637.
    PubMed     Abstract available


  320. LEWIECKI EM, Wright NC, Singer AJ
    Racial disparities, FRAX, and the care of patients with osteoporosis.
    Osteoporos Int. 2020 Sep 26. pii: 10.1007/s00198-020-05655.
    PubMed    


  321. TOMINAGA A, Wada K, Kato Y, Nishi H, et al
    Early clinical effects, safety, and appropriate selection of bone markers in romosozumab treatment for osteoporosis patients: a 6-month study.
    Osteoporos Int. 2020 Sep 26. pii: 10.1007/s00198-020-05639.
    PubMed     Abstract available


  322. ZHANG Q, Greenbaum J, Shen H, Zhao LJ, et al
    Detecting causal relationship between metabolic traits and osteoporosis using multivariable Mendelian randomization.
    Osteoporos Int. 2020 Sep 24. pii: 10.1007/s00198-020-05640.
    PubMed     Abstract available


  323. MOTT A, Bradley T, Wright K, Cockayne ES, et al
    Correction to Effect of vitamin K on bone mineral density and fractures in adults: an updated systematic review and meta-analysis of randomised controlled trials.
    Osteoporos Int. 2020 Sep 23. pii: 10.1007/s00198-020-05586.
    PubMed     Abstract available


  324. MESSINA C, Rinaudo L, Cesana BM, Maresca D, et al
    Prediction of osteoporotic fragility re-fracture with lumbar spine DXA-based derived bone strain index: a multicenter validation study.
    Osteoporos Int. 2020 Sep 16. pii: 10.1007/s00198-020-05620.
    PubMed     Abstract available


  325. HARDING AT, Weeks BK, Lambert C, Watson SL, et al
    Exploring thoracic kyphosis and incident fracture from vertebral morphology with high-intensity exercise in middle-aged and older men with osteopenia and osteoporosis: a secondary analysis of the LIFTMOR-M trial.
    Osteoporos Int. 2020 Sep 15. pii: 10.1007/s00198-020-05583.
    PubMed     Abstract available


  326. WATTS NB, Dore RK, Baim S, Mitlak B, et al
    Forearm bone mineral density and fracture incidence in postmenopausal women with osteoporosis: results from the ACTIVExtend phase 3 trial.
    Osteoporos Int. 2020 Sep 15. pii: 10.1007/s00198-020-05555.
    PubMed     Abstract available


  327. HAMAD AF, Yang S, Yan L, Leslie WD, et al
    The association of objectively ascertained sibling fracture history with major osteoporotic fractures: a population-based cohort study.
    Osteoporos Int. 2020 Sep 15. pii: 10.1007/s00198-020-05635.
    PubMed     Abstract available


  328. GUPTA A, Cha T, Schwab J, Fogel H, et al
    Males Have Higher Rates of Peri-operative Mortality Following Surgery for Osteoporotic Vertebral Compression Fracture.
    Osteoporos Int. 2020 Sep 15. pii: 10.1007/s00198-020-05630.
    PubMed     Abstract available


  329. MUN H, Liu B, Pham THA, Wu Q, et al
    C-reactive protein and fracture risk: an updated systematic review and meta-analysis of cohort studies through the use of both frequentist and Bayesian approaches.
    Osteoporos Int. 2020 Sep 15. pii: 10.1007/s00198-020-05623.
    PubMed     Abstract available


  330. ASANO Y, Tajiri K, Yagishita S, Nakanishi H, et al
    Bilateral atypical ulnar fractures occurring after long-term treatment with bisphosphonate for 7 years and with teriparatide for 2 years: a case report.
    Osteoporos Int. 2020 Sep 10. pii: 10.1007/s00198-020-05618.
    PubMed     Abstract available


  331. VEHMANEN L, Sievanen H, Kellokumpu-Lehtinen P, Nikander R, et al
    Five-year follow-up results of aerobic and impact training on bone mineral density in early breast cancer patients.
    Osteoporos Int. 2020 Sep 4. pii: 10.1007/s00198-020-05611.
    PubMed     Abstract available


  332. JUNG HS, Jang S, Chung HY, Park SY, et al
    Incidence of subsequent osteoporotic fractures after distal radius fractures and mortality of the subsequent distal radius fractures: a retrospective analysis of claims data of the Korea National Health Insurance Service.
    Osteoporos Int. 2020 Sep 2. pii: 10.1007/s00198-020-05609.
    PubMed     Abstract available


  333. GENEST F, Claussen L, Rak D, Seefried L, et al
    Bone mineral density and fracture risk in adult patients with hypophosphatasia.
    Osteoporos Int. 2020 Sep 2. pii: 10.1007/s00198-020-05612.
    PubMed     Abstract available


  334. GOMES-FERREIRA PHS, de Oliveira D, Frigerio PB, de Souza Batista FR, et al
    Teriparatide improves microarchitectural characteristics of peri-implant bone in orchiectomized rats.
    Osteoporos Int. 2020;31:1807-1815.
    PubMed     Abstract available


  335. CLYNES MA, Westbury LD, Dennison EM, Kanis JA, et al
    Bone densitometry worldwide: a global survey by the ISCD and IOF.
    Osteoporos Int. 2020;31:1779-1786.
    PubMed     Abstract available


    August 2020
  336. MCCLOSKEY E, Rathi J, Heijmans S, Blagden M, et al
    The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study.
    Osteoporos Int. 2020 Aug 23. pii: 10.1007/s00198-020-05557.
    PubMed     Abstract available


  337. LEE YF, Tsou HK, Leong PY, Wang YH, et al
    Association of sepsis with risk for osteoporosis: a population-based cohort study.
    Osteoporos Int. 2020 Aug 22. pii: 10.1007/s00198-020-05599.
    PubMed     Abstract available


  338. WANDELL P, Li X, Carlsson AC, Sundquist J, et al
    Osteoporotic fractures among foreign-born individuals: a national Swedish study.
    Osteoporos Int. 2020 Aug 19. pii: 10.1007/s00198-020-05597.
    PubMed     Abstract available


  339. LESLIE WD, Edwards B, Al-Azazi S, Yan L, et al
    Cancer patients with fractures are rarely assessed or treated for osteoporosis: a population-based study.
    Osteoporos Int. 2020 Aug 17. pii: 10.1007/s00198-020-05596.
    PubMed     Abstract available


  340. LI T, Liu WB, Tian FF, Jiang JJ, et al
    Gender-specific SBNO2 and VPS13B as a potential driver of osteoporosis development in male ankylosing spondylitis.
    Osteoporos Int. 2020 Aug 15. pii: 10.1007/s00198-020-05593.
    PubMed     Abstract available


  341. ZHANG TY, Chen XF, Zhan SZ, Wang YH, et al
    Validate the score presented by Yu et al.: "Risk factors and score for recollapse of the augmented vertebrae after percutaneous vertebroplasty in osteoporotic vertebral compression fractures".
    Osteoporos Int. 2020 Aug 15. pii: 10.1007/s00198-020-05598.
    PubMed    


  342. GUO F, Song X, Li Y, Guan W, et al
    Longitudinal change in bone mineral density among Chinese individuals with HIV after initiation of antiretroviral therapy.
    Osteoporos Int. 2020 Aug 15. pii: 10.1007/s00198-020-05584.
    PubMed     Abstract available


  343. CHANDRAN M, Ganesan G, Tan KB, Reginster JY, et al
    Cost-effectiveness of FRAX(R)-based intervention thresholds for management of osteoporosis in Singaporean women.
    Osteoporos Int. 2020 Aug 14. pii: 10.1007/s00198-020-05536.
    PubMed     Abstract available


  344. HO-LE TP, Tran HTT, Center JR, Eisman JA, et al
    Assessing the clinical utility of genetic profiling in fracture risk prediction: a decision curve analysis.
    Osteoporos Int. 2020 Aug 12. pii: 10.1007/s00198-020-05403.
    PubMed     Abstract available


  345. LESPESSAILLES E, Chapurlat R
    High fracture risk patients with glucocorticoid-induced osteoporosis should get an anabolic treatment first.
    Osteoporos Int. 2020 Aug 11. pii: 10.1007/s00198-020-05568.
    PubMed     Abstract available


  346. YANG J, Cosman F, Stone PW, Li M, et al
    Vertebral fracture assessment (VFA) for osteoporosis screening in US postmenopausal women: is it cost-effective?
    Osteoporos Int. 2020 Aug 11. pii: 10.1007/s00198-020-05588.
    PubMed     Abstract available


  347. QIAN BB, Chen Q, Li L, Yan CF, et al
    Association between combined treatment with SGLT2 inhibitors and metformin for type 2 diabetes mellitus on fracture risk: a meta-analysis of randomized controlled trials.
    Osteoporos Int. 2020 Aug 11. pii: 10.1007/s00198-020-05590.
    PubMed     Abstract available


  348. THOMAS T, Casado E, Geusens P, Lems WF, et al
    Is a treat-to-target strategy in osteoporosis applicable in clinical practice? Consensus among a panel of European experts.
    Osteoporos Int. 2020 Aug 7. pii: 10.1007/s00198-020-05569.
    PubMed     Abstract available


  349. ALI MS, Berencsi K, Marinier K, Deltour N, et al
    Comparative cardiovascular safety of strontium ranelate and bisphosphonates: a multi-database study in 5 EU countries by the EU-ADR Alliance.
    Osteoporos Int. 2020 Aug 5. pii: 10.1007/s00198-020-05580.
    PubMed     Abstract available


  350. DUERKSEN DR, Lix LM, Johansson H, McCloskey EV, et al
    Fracture risk assessment in celiac disease: a registry-based cohort study.
    Osteoporos Int. 2020 Aug 3. pii: 10.1007/s00198-020-05579.
    PubMed     Abstract available


  351. JOHANNESDOTTIR F, Allaire B, Kopperdahl DL, Keaveny TM, et al
    Bone density and strength from thoracic and lumbar CT scans both predict incident vertebral fractures independently of fracture location.
    Osteoporos Int. 2020 Aug 3. pii: 10.1007/s00198-020-05528.
    PubMed     Abstract available


  352. TANG J
    What can we learn about corticosteroid therapy as a treatment for COVID-19?
    Osteoporos Int. 2020;31:1595.
    PubMed    


  353. FANG Y, Zhu J, Fan J, Sun L, et al
    Dietary Inflammatory Index in relation to bone mineral density, osteoporosis risk and fracture risk: a systematic review and meta-analysis.
    Osteoporos Int. 2020 Aug 1. pii: 10.1007/s00198-020-05578.
    PubMed     Abstract available


    July 2020
  354. FU Y, Li C, Luo W, Chen Z, et al
    Fragility fracture discriminative ability of radius quantitative ultrasound: a systematic review and meta-analysis.
    Osteoporos Int. 2020 Jul 30. pii: 10.1007/s00198-020-05559.
    PubMed     Abstract available


  355. ZHU K, Hunter M, James A, Lim EM, et al
    Relationship between visceral adipose tissue and bone mineral density in Australian baby boomers.
    Osteoporos Int. 2020 Jul 27. pii: 10.1007/s00198-020-05556.
    PubMed     Abstract available


  356. KENDLER DL, Adachi JD, Brown JP, Juby AG, et al
    A scorecard for osteoporosis in Canada and seven Canadian provinces.
    Osteoporos Int. 2020 Jul 25. pii: 10.1007/s00198-020-05554.
    PubMed     Abstract available


  357. NASOMYONT N, Keefe C, Tian C, Hornung L, et al
    Safety and efficacy of teriparatide treatment for severe osteoporosis in patients with Duchenne muscular dystrophy.
    Osteoporos Int. 2020 Jul 17. pii: 10.1007/s00198-020-05549.
    PubMed     Abstract available


  358. LEWIECKI EM, Binkley N, Clark P, Kim S, et al
    Core principles for fracture prevention: North American Consensus from the National Osteoporosis Foundation, Osteoporosis Canada, and Academia Nacional de Medicina de Mexico.
    Osteoporos Int. 2020 Jul 16. pii: 10.1007/s00198-020-05541.
    PubMed     Abstract available


  359. NGUYEN PV, Bouin M, Ste-Marie LG
    Upper gastrointestinal safety of oral bisphosphonate in hospitalized patients.
    Osteoporos Int. 2020 Jul 14. pii: 10.1007/s00198-020-05498.
    PubMed     Abstract available


  360. MAZZUCCHELLI R, Rodriguez-Martin S, Garcia-Vadillo A, Crespi-Villarias N, et al
    Risk of acute myocardial infarction among new users of bisphosphonates: a nested case-control study.
    Osteoporos Int. 2020 Jul 14. pii: 10.1007/s00198-020-05538.
    PubMed     Abstract available


  361. MATSUMOTO K, Ogawa H, Nozawa S, Akiyama H, et al
    An analysis of osteoporosis in patients with hereditary multiple exostoses.
    Osteoporos Int. 2020 Jul 8. pii: 10.1007/s00198-020-05533.
    PubMed     Abstract available


  362. ROZENBERG S, Al-Daghri N, Aubertin-Leheudre M, Brandi ML, et al
    Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?
    Osteoporos Int. 2020 Jul 8. pii: 10.1007/s00198-020-05497.
    PubMed     Abstract available


  363. HYUN YY, Lee KB, Han SH, Choi KH, et al
    Risk factors and renal outcomes of low bone mineral density in patients with non-dialysis chronic kidney disease.
    Osteoporos Int. 2020 Jul 8. pii: 10.1007/s00198-020-05531.
    PubMed     Abstract available


  364. CHOI HG, Lee JK, Lee MJ, Park B, et al
    Blindness increases the risk for hip fracture and vertebral fracture but not the risk for distal radius fracture: a longitudinal follow-up study using a national sample cohort.
    Osteoporos Int. 2020 Jul 6. pii: 10.1007/s00198-020-05475.
    PubMed     Abstract available


  365. JAIN RK, Lee E, Mathai C, Dako F, et al
    Using opportunistic screening with abdominal CT to identify osteoporosis and osteopenia in patients with diabetes.
    Osteoporos Int. 2020 Jul 5. pii: 10.1007/s00198-020-05521.
    PubMed     Abstract available


  366. MCCLUNG MR, Bolognese MA, Brown JP, Reginster JY, et al
    A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab.
    Osteoporos Int. 2020 Jul 4. pii: 10.1007/s00198-020-05502.
    PubMed     Abstract available


  367. YOKOMOTO-UMAKOSHI M, Umakoshi H, Ogata M, Fukumoto T, et al
    Coexistence of osteoporosis and atherosclerosis in pheochromocytoma: new insights into its long-term management.
    Osteoporos Int. 2020 Jul 2. pii: 10.1007/s00198-020-05527.
    PubMed     Abstract available


  368. BARRON RL, Oster G, Grauer A, Crittenden DB, et al
    Determinants of imminent fracture risk in postmenopausal women with osteoporosis.
    Osteoporos Int. 2020 Jul 1. pii: 10.1007/s00198-020-05294.
    PubMed     Abstract available


  369. KOLLER G, Goetz V, Vandermeer B, Homik J, et al
    Persistence and adherence to parenteral osteoporosis therapies: a systematic review.
    Osteoporos Int. 2020 Jul 1. pii: 10.1007/s00198-020-05507.
    PubMed     Abstract available


    June 2020
  370. VAN CAMP L, Dejaeger M, Tournoy J, Gielen E, et al
    Association of orthogeriatric care models with evaluation and treatment of osteoporosis: a systematic review and meta-analysis.
    Osteoporos Int. 2020 Jun 27. pii: 10.1007/s00198-020-05512.
    PubMed     Abstract available


  371. CHRISTENSEN DL, Nappo KE, Wolfe JA, Tropf JG, et al
    Ten-year fracture risk predicted by proximal femur Hounsfield units.
    Osteoporos Int. 2020 Jun 27. pii: 10.1007/s00198-020-05477.
    PubMed     Abstract available


  372. PIPONOV HI, Goldstein JM, Eisenberg GM
    Multiple ipsilateral femoral stress fractures in a patient taking denosumab for osteoporosis-a case report.
    Osteoporos Int. 2020 Jun 20. pii: 10.1007/s00198-020-05499.
    PubMed     Abstract available


  373. CHANDRAN M, Bhadada SK, Ebeling PR, Gilchrist NL, et al
    IQ driving QI: the Asia Pacific Consortium on Osteoporosis (APCO): an innovative and collaborative initiative to improve osteoporosis care in the Asia Pacific.
    Osteoporos Int. 2020 Jun 19. pii: 10.1007/s00198-020-05495.
    PubMed     Abstract available


  374. SHAHRIARPOUR Z, Nasrabadi B, Shariati-Bafghi SE, Karamati M, et al
    Adherence to the dietary approaches to stop hypertension (DASH) dietary pattern and osteoporosis risk in postmenopausal Iranian women.
    Osteoporos Int. 2020 Jun 18. pii: 10.1007/s00198-020-05450.
    PubMed     Abstract available


  375. PASKINS Z, Crawford-Manning F, Bullock L, Jinks C, et al
    Identifying and managing osteoporosis before and after COVID-19: rise of the remote consultation?
    Osteoporos Int. 2020 Jun 16. pii: 10.1007/s00198-020-05465.
    PubMed     Abstract available


  376. KASHER M, Williams FMK, Freidin MB, Cherny S, et al
    An in-depth study of the associations between osteoarthritis- and osteoporosis-related phenotypes at different skeletal locations.
    Osteoporos Int. 2020 Jun 16. pii: 10.1007/s00198-020-05504.
    PubMed     Abstract available


  377. WATTS NB, Hattersley G, Fitzpatrick LA, Wang Y, et al
    Correction to: Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis.
    Osteoporos Int. 2020 Jun 12. pii: 10.1007/s00198-020-05469.
    PubMed     Abstract available


  378. HO P, Tan EF, Su S, Mallya J, et al
    Correspondence to "Denosumab-induced hypocalcemia in patients with osteoporosis: can you know who will get low?"
    Osteoporos Int. 2020 Jun 12. pii: 10.1007/s00198-020-05491.
    PubMed    


  379. TSVETOV G, Amitai O, Diker-Cohen T
    Response to letter to the editor OSIN-D-20-00441 re: "Denosumab-induced hypocalcemia in patients with osteoporosis: can you know who will get low?"
    Osteoporos Int. 2020 Jun 12. pii: 10.1007/s00198-020-05492.
    PubMed    


  380. SANSAI K, Na Takuathung M, Khatsri R, Teekachunhatean S, et al
    Effects of isoflavone interventions on bone mineral density in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials.
    Osteoporos Int. 2020 Jun 10. pii: 10.1007/s00198-020-05476.
    PubMed     Abstract available


  381. WANG YXJ, Che-Nordin N, Leung JCS, Kwok TCY, et al
    Existing severe osteoporotic vertebral fractures in elderly Chinese males were only weakly associated with higher further vertebral fracture risk at year-4 follow-up.
    Osteoporos Int. 2020 Jun 9. pii: 10.1007/s00198-020-05480.
    PubMed    


  382. SHIN A, Park EH, Dong YH, Ha YJ, et al
    Comparative risk of osteoporotic fracture among patients with rheumatoid arthritis receiving TNF inhibitors versus other biologics: a cohort study.
    Osteoporos Int. 2020 Jun 8. pii: 10.1007/s00198-020-05488.
    PubMed     Abstract available


  383. ELHAKEEM A, Hartley A, Luo Y, Goertzen AL, et al
    Correction to: Lean mass and lower limb muscle function in relation to hip strength, geometry and fracture risk indices in community-dwelling older women.
    Osteoporos Int. 2020 Jun 8. pii: 10.1007/s00198-020-05460.
    PubMed     Abstract available


  384. PASKINS Z, Torres Roldan VD, Hawarden AW, Bullock L, et al
    Quality and effectiveness of osteoporosis treatment decision aids: a systematic review and environmental scan.
    Osteoporos Int. 2020 Jun 5. pii: 10.1007/s00198-020-05479.
    PubMed     Abstract available


  385. SALE JEM, Frankel L, Bogoch E, Gignac M, et al
    Few fragility fracture patients perceive that their bone health is affected by their comorbidities and medications.
    Osteoporos Int. 2020 Jun 5. pii: 10.1007/s00198-020-05409.
    PubMed     Abstract available


  386. KIM SY, Kim HJ, Min C, Choi HG, et al
    Association between benign paroxysmal positional vertigo and osteoporosis: two nested case-control studies.
    Osteoporos Int. 2020 Jun 1. pii: 10.1007/s00198-020-05478.
    PubMed     Abstract available


  387. CUMMINGS SR, McCulloch C
    Explanations for the difference in rates of cardiovascular events in a trial of alendronate and romosozumab.
    Osteoporos Int. 2020;31:1019-1021.
    PubMed    


    May 2020
  388. BODY JJ, Marin F, Kendler DL, Zerbini CAF, et al
    Efficacy of teriparatide compared with risedronate on FRAX((R))-defined major osteoporotic fractures: results of the VERO clinical trial.
    Osteoporos Int. 2020 May 30. pii: 10.1007/s00198-020-05463.
    PubMed     Abstract available


  389. WHITTIER DE, Boyd SK, Burghardt AJ, Paccou J, et al
    Guidelines for the assessment of bone density and microarchitecture in vivo using high-resolution peripheral quantitative computed tomography.
    Osteoporos Int. 2020 May 26. pii: 10.1007/s00198-020-05438.
    PubMed     Abstract available


  390. JAZINIZADEH F, Adachi JD, Quenneville CE
    Advanced 2D image processing technique to predict hip fracture risk in an older population based on single DXA scans.
    Osteoporos Int. 2020 May 15. pii: 10.1007/s00198-020-05444.
    PubMed     Abstract available


  391. VAN DEN BERG P, van Haard PMM, Geusens PP, van den Bergh JP, et al
    Characterization of fracture liaison service non-responders after invitation by home visits and questionnaires.
    Osteoporos Int. 2020 May 13. pii: 10.1007/s00198-020-05442.
    PubMed     Abstract available


  392. SHOJAA M, von Stengel S, Kohl M, Schoene D, et al
    Effects of dynamic resistance exercise on bone mineral density in postmenopausal women: a systematic review and meta-analysis with special emphasis on exercise parameters.
    Osteoporos Int. 2020 May 12. pii: 10.1007/s00198-020-05441.
    PubMed     Abstract available


  393. KWON YE, Choi HY, Oh HJ, Ahn SY, et al
    Vertebral fracture is associated with myocardial infarction in incident hemodialysis patients: a Korean nationwide population-based study.
    Osteoporos Int. 2020 May 11. pii: 10.1007/s00198-020-05423.
    PubMed     Abstract available


  394. BASSATNE A, Harb H, Jaafar B, Romanos J, et al
    Disease burden of osteoporosis and other non-communicable diseases in Lebanon.
    Osteoporos Int. 2020 May 6. pii: 10.1007/s00198-020-05433.
    PubMed     Abstract available


  395. KYVERNITAKIS I, Kostev K, Thomasius F, Stumpf U, et al
    Effect of progestogen-only contraception on premenopausal fracture risk: a case-control study.
    Osteoporos Int. 2020 May 6. pii: 10.1007/s00198-020-05437.
    PubMed     Abstract available


  396. SOTO-SUBIABRE M, Mayoral V, Fiter J, Valencia L, et al
    Vertebral fracture: clinical presentation and severity are linked to fracture risk factors.
    Osteoporos Int. 2020 May 6. pii: 10.1007/s00198-020-05425.
    PubMed    


  397. AUL AJ, Dudenkov DV, Mara KC, Juhn YJ, et al
    The relationship of 25-hydroxyvitamin D values and risk of fracture: a population-based retrospective cohort study.
    Osteoporos Int. 2020 May 6. pii: 10.1007/s00198-020-05436.
    PubMed     Abstract available


  398. CAI G, Keen HI, Host LV, Aitken D, et al
    Once-yearly zoledronic acid and change in abdominal aortic calcification over 3 years in postmenopausal women with osteoporosis: results from the HORIZON Pivotal Fracture Trial.
    Osteoporos Int. 2020 May 2. pii: 10.1007/s00198-020-05430.
    PubMed     Abstract available


  399. JALILI C, Kazemi M, Taheri E, Mohammadi H, et al
    Exposure to heavy metals and the risk of osteopenia or osteoporosis: a systematic review and meta-analysis.
    Osteoporos Int. 2020 May 2. pii: 10.1007/s00198-020-05429.
    PubMed     Abstract available


  400. CORNELISSEN D, de Kunder S, Si L, Reginster JY, et al
    Interventions to improve adherence to anti-osteoporosis medications: an updated systematic review.
    Osteoporos Int. 2020 May 1. pii: 10.1007/s00198-020-05378.
    PubMed     Abstract available


    April 2020
  401. GIRGIS CM, Clifton-Bligh RJ
    Osteoporosis in the age of COVID-19.
    Osteoporos Int. 2020 Apr 28. pii: 10.1007/s00198-020-05413.
    PubMed     Abstract available


  402. JIN H, Ma X, Liu Y, Liu M, et al
    Back pain from painful osteoporotic vertebral fractures: discrepancy between the actual fracture location and the location suggested by patient-reported pain or physical examination findings.
    Osteoporos Int. 2020 Apr 28. pii: 10.1007/s00198-020-05434.
    PubMed     Abstract available


  403. STANGHELLE B, Bentzen H, Giangregorio L, Pripp AH, et al
    Correction to: Effects of a resistance and balance exercise programme on physical fitness, health-related quality of life and fear of falling in older women with osteoporosis and vertebral fracture: a randomized controlled trial.
    Osteoporos Int. 2020 Apr 27. pii: 10.1007/s00198-020-05398.
    PubMed     Abstract available


  404. KEAVENY TM, Clarke BL, Cosman F, Orwoll ES, et al
    Biomechanical Computed Tomography analysis (BCT) for clinical assessment of osteoporosis.
    Osteoporos Int. 2020 Apr 26. pii: 10.1007/s00198-020-05384.
    PubMed     Abstract available


  405. LINTON DN, Porteous J, Eatson H, Chepesiuk R, et al
    Educational booklet reinforces knowledge of osteoporosis and influences intentions to improve bone health in previously diagnosed and treated patients.
    Osteoporos Int. 2020 Apr 24. pii: 10.1007/s00198-020-05392.
    PubMed     Abstract available


  406. MCCLOSKEY E, Harvey N, Johansson H, Lorentzon M, et al
    Screening for high fracture risk.
    Osteoporos Int. 2020 Apr 24. pii: 10.1007/s00198-020-05416.
    PubMed    


  407. MERLIJN T, Swart KMA, Netelenbos JC, Elders PJM, et al
    Reply to "Screening for high fracture risk".
    Osteoporos Int. 2020 Apr 24. pii: 10.1007/s00198-020-05417.
    PubMed    


  408. ZHANG H, Liu L, Ni JJ, Wei XT, et al
    Pleiotropic loci underlying bone mineral density and bone size identified by a bivariate genome-wide association analysis.
    Osteoporos Int. 2020 Apr 20. pii: 10.1007/s00198-020-05389.
    PubMed     Abstract available


  409. SHIN YH, Hong WK, Kim J, Gong HS, et al
    Osteoporosis care after distal radius fracture reduces subsequent hip or spine fractures: a 4-year longitudinal study.
    Osteoporos Int. 2020 Apr 16. pii: 10.1007/s00198-020-05410.
    PubMed     Abstract available


  410. WANG Y, Zhao R, Gu Z, Dong C, et al
    Effects of glucocorticoids on osteoporosis in rheumatoid arthritis: a systematic review and meta-analysis.
    Osteoporos Int. 2020 Apr 14. pii: 10.1007/s00198-020-05360.
    PubMed     Abstract available


  411. CAVALIER E, Lukas P, Bottani M, Aarsand AK, et al
    European Biological Variation Study (EuBIVAS): within- and between-subject biological variation estimates of beta-isomerized C-terminal telopeptide of type I collagen (beta-CTX), N-terminal propeptide of type I collagen (PINP), osteocalcin, intact fib
    Osteoporos Int. 2020 Apr 8. pii: 10.1007/s00198-020-05362.
    PubMed     Abstract available


  412. SCHOEB M, Malgo F, Peeters JJM, Winter EM, et al
    Treatments of osteoporosis increase bone material strength index in patients with low bone mass.
    Osteoporos Int. 2020 Apr 8. pii: 10.1007/s00198-020-05375.
    PubMed     Abstract available


  413. JAVAID MK, Sami A, Lems W, Mitchell P, et al
    A patient-level key performance indicator set to measure the effectiveness of fracture liaison services and guide quality improvement: a position paper of the IOF Capture the Fracture Working Group, National Osteoporosis Foundation and Fragility Fract
    Osteoporos Int. 2020 Apr 8. pii: 10.1007/s00198-020-05377.
    PubMed     Abstract available


  414. ABOUDIAB M, Grados F, Batteux B, Henry-Desailly I, et al
    Vertebral fracture assessment (VFA) in patients over 50 years of age with a non-severe peripheral fracture.
    Osteoporos Int. 2020 Apr 7. pii: 10.1007/s00198-020-05400.
    PubMed     Abstract available


  415. SORESKOG E, Borgstrom F, Shepstone L, Clarke S, et al
    Long-term cost-effectiveness of screening for fracture risk in a UK primary care setting: the SCOOP study.
    Osteoporos Int. 2020 Apr 1. pii: 10.1007/s00198-020-05372.
    PubMed     Abstract available


  416. THOMPSON MJW, Jones G, Balogun S, Aitken DA, et al
    Constitutive melanin density is associated with prevalent and short-term, but not long-term, incident fracture risk in older Caucasian adults.
    Osteoporos Int. 2020 Apr 1. pii: 10.1007/s00198-020-05304.
    PubMed     Abstract available


  417. LIU Y, Dash A, Krez A, Kim HJ, et al
    Low volumetric bone density is a risk factor for early complications after spine fusion surgery.
    Osteoporos Int. 2020;31:647-654.
    PubMed     Abstract available


  418. VAN BODEGRAVEN AA, Bravenboer N
    Perspective on skeletal health in inflammatory bowel disease.
    Osteoporos Int. 2020;31:637-646.
    PubMed     Abstract available


  419. GEIKER NRW, Molgaard C, Iuliano S, Rizzoli R, et al
    Impact of whole dairy matrix on musculoskeletal health and aging-current knowledge and research gaps.
    Osteoporos Int. 2020;31:601-615.
    PubMed     Abstract available


  420. VIETH R
    Weaker bones and white skin as adaptions to improve anthropological "fitness" for northern environments.
    Osteoporos Int. 2020;31:617-624.
    PubMed     Abstract available


    March 2020
  421. STROM O, Lauppe R, Ljunggren O, Spangeus A, et al
    Real-world effectiveness of osteoporosis treatment in the oldest old.
    Osteoporos Int. 2020 Mar 30. pii: 10.1007/s00198-020-05380.
    PubMed     Abstract available


  422. WATTS NB, Hattersley G, Fitzpatrick LA, Wang Y, et al
    Correction to: Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis.
    Osteoporos Int. 2020 Mar 30. pii: 10.1007/s00198-020-05349.
    PubMed     Abstract available


  423. CHEN YJ, Kung PT, Chou WY, Tsai WC, et al
    Alendronate medication possession ratio and the risk of second hip fracture: an 11-year population-based cohort study in Taiwan.
    Osteoporos Int. 2020 Mar 27. pii: 10.1007/s00198-020-05399.
    PubMed     Abstract available


  424. PREMAOR MO, Compston JE
    People living with HIV and fracture risk.
    Osteoporos Int. 2020 Mar 23. pii: 10.1007/s00198-020-05350.
    PubMed     Abstract available


  425. MCKEE H, Ioannidis G, Lau A, Treleaven D, et al
    Correction to: Comparison of the clinical effectiveness and safety between the use of denosumab vs bisphosphonates in renal transplant patients.
    Osteoporos Int. 2020 Mar 18. pii: 10.1007/s00198-020-05381.
    PubMed     Abstract available


  426. COLANGELO L, Pepe J, Nieddu L, Sonato C, et al
    Long-term bone mineral density changes after surgical cure of patients with tumor-induced osteomalacia.
    Osteoporos Int. 2020 Mar 17. pii: 10.1007/s00198-020-05369.
    PubMed     Abstract available


  427. PASCO JA, Mohebbi M, Tembo MC, Holloway-Kew KL, et al
    Repurposing a fracture risk calculator (FRAX) as a screening tool for women at risk for sarcopenia.
    Osteoporos Int. 2020 Mar 17. pii: 10.1007/s00198-020-05376.
    PubMed     Abstract available


  428. LESLIE WD, Schousboe JT, Morin SN, Martineau P, et al
    Fracture risk following high-trauma versus low-trauma fracture: a registry-based cohort study.
    Osteoporos Int. 2020 Mar 16. pii: 10.1007/s00198-019-05274.
    PubMed     Abstract available


  429. ZHOU J, Xue Y
    Depression, falls, and osteoporotic fractures.
    Osteoporos Int. 2020 Mar 13. pii: 10.1007/s00198-020-05347.
    PubMed    


  430. OKANO I, Jones C, Salzmann SN, Miller CO, et al
    Postoperative decrease of regional volumetric bone mineral density measured by quantitative computed tomography after lumbar fusion surgery in adjacent vertebrae.
    Osteoporos Int. 2020 Mar 13. pii: 10.1007/s00198-020-05367.
    PubMed     Abstract available


  431. PARULEKAR AD, Wang T, Li GW, Hoang V, et al
    Pectoralis muscle area is associated with bone mineral density and lung function in lung transplant candidates.
    Osteoporos Int. 2020 Mar 13. pii: 10.1007/s00198-020-05373.
    PubMed     Abstract available


  432. CUI R, Sun SQ, Zhong N, Xu MX, et al
    The relationship between atherosclerosis and bone mineral density in patients with type 2 diabetes depends on vascular calcifications and sex.
    Osteoporos Int. 2020 Mar 10. pii: 10.1007/s00198-020-05374.
    PubMed     Abstract available


  433. KIM CH, Kim JW
    Letter to the editor about the article "Different surgical outcomes in a patient with bilateral atypical femoral fracture related to bisphosphonate use with or without teriparatide treatment".
    Osteoporos Int. 2020 Mar 6. pii: 10.1007/s00198-020-05354.
    PubMed    


  434. ICONARU L, Smeys C, Baleanu F, Kinnard V, et al
    Osteoporosis treatment gap in a prospective cohort of volunteer women.
    Osteoporos Int. 2020 Mar 3. pii: 10.1007/s00198-020-05339.
    PubMed     Abstract available


  435. GRIZZO FMF, Alarcao ACJ, Dell' Agnolo CM, Pedroso RB, et al
    How does women's bone health recover after lactation? A systematic review and meta-analysis.
    Osteoporos Int. 2020;31:413-427.
    PubMed     Abstract available


  436. OHBAYASHI Y, Iwasaki A, Nakai F, Mashiba T, et al
    A comparative effectiveness pilot study of teriparatide for medication-related osteonecrosis of the jaw: daily versus weekly administration.
    Osteoporos Int. 2020;31:577-585.
    PubMed     Abstract available


    February 2020
  437. CHAO CT, Wang J, Huang JW, Chan DC, et al
    Chronic kidney disease-related osteoporosis is associated with incident frailty among patients with diabetic kidney disease: a propensity score-matched cohort study.
    Osteoporos Int. 2020 Feb 27. pii: 10.1007/s00198-020-05353.
    PubMed     Abstract available


  438. ZHOU J, Huo X, Xue Y
    Comments on Min et al.: Effects of anti-osteoporosis medications on radiological and clinical results after acute osteoporotic spinal fractures: a retrospective analysis of prospectively designed study.
    Osteoporos Int. 2020 Feb 22. pii: 10.1007/s00198-020-05355.
    PubMed    


  439. HOLLICK RJ, McKee L, Shim J, Ramsay N, et al
    Introducing mobile fracture prevention services with DXA in Northern Scotland: a comparative study of three rural communities.
    Osteoporos Int. 2020 Feb 21. pii: 10.1007/s00198-020-05316.
    PubMed     Abstract available


  440. ALARCON T, Ojeda-Thies C, Saez-Lopez P, Gomez-Campelo P, et al
    Usefulness of a national hip fracture registry to evaluate the profile of patients in whom antiosteoporotic treatment is prescribed following hospital discharge.
    Osteoporos Int. 2020 Feb 20. pii: 10.1007/s00198-020-05341.
    PubMed     Abstract available


  441. KANIS JA, Cooper C, Rizzoli R, Reginster JY, et al
    Correction to: European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
    Osteoporos Int. 2020 Feb 18. pii: 10.1007/s00198-020-05303.
    PubMed     Abstract available


  442. KANIS JA, Harvey NC, McCloskey E, Bruyere O, et al
    Correction to: Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures.
    Osteoporos Int. 2020 Feb 17. pii: 10.1007/s00198-020-05297.
    PubMed     Abstract available


  443. LEWIECKI EM, Chastek B, Sundquist K, Williams SA, et al
    Osteoporotic fracture trends in a population of US managed care enrollees from 2007 to 2017.
    Osteoporos Int. 2020 Feb 15. pii: 10.1007/s00198-020-05334.
    PubMed     Abstract available


  444. TAKAHASHI S, Hoshino M, Takayama K, Sasaoka R, et al
    The natural course of the paravertebral muscles after the onset of osteoporotic vertebral fracture.
    Osteoporos Int. 2020 Feb 14. pii: 10.1007/s00198-020-05338.
    PubMed     Abstract available


  445. LAU EMC, Dinavahi R, Woo YC, Wu CH, et al
    Romosozumab or alendronate for fracture prevention in East Asian patients: a subanalysis of the phase III, randomized ARCH study.
    Osteoporos Int. 2020 Feb 11. pii: 10.1007/s00198-020-05324.
    PubMed     Abstract available


  446. DE BOT RTAL, Veldman HD, Witlox AM, van Rhijn LW, et al
    Hip protectors are cost-effective in the prevention of hip fractures in patients with high fracture risk.
    Osteoporos Int. 2020 Feb 10. pii: 10.1007/s00198-019-05252.
    PubMed     Abstract available


  447. PAPAIOANNOU A, Adachi JD, Berger C, Jiang Y, et al
    Testing a theoretical model of imminent fracture risk in elderly women: an observational cohort analysis of the Canadian Multicentre Osteoporosis Study.
    Osteoporos Int. 2020 Feb 7. pii: 10.1007/s00198-020-05330.
    PubMed     Abstract available


  448. CHOI D, Choi S, Chang J, Park SM, et al
    Exposure to oral bisphosphonates and risk of gastrointestinal cancer.
    Osteoporos Int. 2020 Feb 7. pii: 10.1007/s00198-020-05327.
    PubMed     Abstract available


  449. NAYAK S, Greenspan SL
    Cost-effectiveness of five versus ten years of alendronate treatment prior to drug holiday for women with osteoporosis.
    Osteoporos Int. 2020 Feb 4. pii: 10.1007/s00198-019-05258.
    PubMed     Abstract available


  450. ADAMI G, Saag KG, Mudano AS, Rahn EJ, et al
    Factors associated with the contemplative stage of readiness to initiate osteoporosis treatment.
    Osteoporos Int. 2020 Feb 4. pii: 10.1007/s00198-020-05312.
    PubMed     Abstract available


  451. LESLIE WD, Schousboe JT, Morin SN, Martineau P, et al
    Measured height loss predicts incident clinical fractures independently from FRAX: a registry-based cohort study.
    Osteoporos Int. 2020 Feb 3. pii: 10.1007/s00198-020-05313.
    PubMed     Abstract available


  452. WONGTRAKUL W, Charoenngam N, Ungprasert P
    The association between irritable bowel syndrome and osteoporosis: a systematic review and meta-analysis.
    Osteoporos Int. 2020 Feb 1. pii: 10.1007/s00198-020-05318.
    PubMed     Abstract available


  453. ISAKSSON S, Bogefors K, Akesson K, Ora I, et al
    Low bone mineral density is associated with hypogonadism and cranial irradiation in male childhood cancer survivors.
    Osteoporos Int. 2020 Feb 1. pii: 10.1007/s00198-020-05285.
    PubMed     Abstract available


    January 2020
  454. DING LL, Wen F, Wang H, Wang DH, et al
    Osteoporosis drugs for prevention of clinical fracture in white postmenopausal women: a network meta-analysis of survival data.
    Osteoporos Int. 2020 Jan 30. pii: 10.1007/s00198-019-05183.
    PubMed     Abstract available


  455. RUIZ-ADAME M, Correa M
    A systematic review of the indirect and social costs studies in fragility fractures.
    Osteoporos Int. 2020 Jan 30. pii: 10.1007/s00198-020-05319.
    PubMed     Abstract available


  456. MARTIN J, Viprey M, Castagne B, Merle B, et al
    Interventions to improve osteoporosis care: a systematic review and meta-analysis.
    Osteoporos Int. 2020 Jan 28. pii: 10.1007/s00198-020-05308.
    PubMed     Abstract available


  457. YOSHIDA T, Kinoshita H, Taniguchi H, Yanishi M, et al
    A randomized, open-label, controlled trial of monthly oral minodronate or semiannual subcutaneous injection of denosumab for bone loss by androgen deprivation in Asian men with prostate cancer: the PRevention of Osteopenia with Minodronate And DEnosum
    Osteoporos Int. 2020 Jan 28. pii: 10.1007/s00198-019-05271.
    PubMed     Abstract available


  458. PAGGIOSI MA, Debono M, Walsh JS, Peel NFA, et al
    Quantitative computed tomography discriminates between postmenopausal women with low spine bone mineral density with vertebral fractures and those with low spine bone mineral density only: the SHATTER study.
    Osteoporos Int. 2020 Jan 28. pii: 10.1007/s00198-020-05317.
    PubMed     Abstract available


  459. CONDURACHE CI, Chiu S, Chotiyarnwong P, Johansson H, et al
    Screening for high hip fracture risk does not impact on falls risk: a post hoc analysis from the SCOOP study.
    Osteoporos Int. 2020 Jan 20. pii: 10.1007/s00198-019-05270.
    PubMed     Abstract available


  460. ADAMI G, Rossini M, Fassio A, Viapiana O, et al
    Comments on Kanis et al.: Algorithm for the management of patients at low, high, and very high risk of osteoporotic fractures.
    Osteoporos Int. 2020 Jan 17. pii: 10.1007/s00198-020-05302.
    PubMed    


  461. MUGNIER B, Daumas A, Doddoli S, Belmeliani S, et al
    Adherence to fracture liaison service programs in patients over 70: the hidden part of the iceberg.
    Osteoporos Int. 2020 Jan 11. pii: 10.1007/s00198-020-05290.
    PubMed     Abstract available


  462. STANGHELLE B, Bentzen H, Giangregorio L, Pripp AH, et al
    Effects of a resistance and balance exercise programme on physical fitness, health-related quality of life and fear of falling in older women with osteoporosis and vertebral fracture: a randomized controlled trial.
    Osteoporos Int. 2020 Jan 10. pii: 10.1007/s00198-019-05256.
    PubMed     Abstract available


  463. SIMON D, Haschka J, Muschitz C, Kocijan A, et al
    Bone microstructure and volumetric bone mineral density in patients with hyperuricemia with and without psoriasis.
    Osteoporos Int. 2020 Jan 10. pii: 10.1007/s00198-019-05160.
    PubMed     Abstract available


  464. MCKEE H, Ioannidis G, Lau A, Treleaven D, et al
    Comparison of the clinical effectiveness and safety between the use of denosumab vs bisphosphonates in renal transplant patients.
    Osteoporos Int. 2020 Jan 3. pii: 10.1007/s00198-019-05267.
    PubMed     Abstract available


  465. BOUXSEIN ML, Zysset P, Gluer CC, McClung M, et al
    Perspectives on the non-invasive evaluation of femoral strength in the assessment of hip fracture risk.
    Osteoporos Int. 2020 Jan 3. pii: 10.1007/s00198-019-05195.
    PubMed     Abstract available


  466. IERVOLINO LL, Ferraz-de-Souza B, Martin RM, Costa FC, et al
    Real-world impact of glucocorticoid replacement therapy on bone mineral density: retrospective experience of a large single-center CAH cohort spanning 24 years.
    Osteoporos Int. 2020 Jan 2. pii: 10.1007/s00198-019-05268.
    PubMed     Abstract available


  467. CHIU WY, Lin CJ, Yang WS, Tsai KS, et al
    Racial difference in bioavailability of oral ibandronate between Caucasian and Taiwanese postmenopausal women.
    Osteoporos Int. 2020;31:193-201.
    PubMed     Abstract available


    December 2019
  468. KO Y, Lee G, Kim B, Park M, et al
    Modification of the RANKL-RANK-binding site for the immunotherapeutic treatment of osteoporosis.
    Osteoporos Int. 2019 Dec 20. pii: 10.1007/s00198-019-05200.
    PubMed     Abstract available


  469. LANYAN A, Marques-Vidal P, Gonzalez-Rodriguez E, Hans D, et al
    Postmenopausal women with osteoporosis consume high amounts of vegetables but insufficient dairy products and calcium to benefit from their virtues: the CoLaus/OsteoLaus cohort.
    Osteoporos Int. 2019 Dec 17. pii: 10.1007/s00198-019-05225.
    PubMed     Abstract available


  470. LOPEZ-OLIVO MA, des Bordes JKA, Lin H, Rizvi T, et al
    Comparison of multimedia and printed patient education tools for patients with osteoporosis: a 6-month randomized controlled trial.
    Osteoporos Int. 2019 Dec 16. pii: 10.1007/s00198-019-05210.
    PubMed     Abstract available


  471. MORIN SN, Djekic-Ivankovic M, Funnell L, Giangregorio L, et al
    Patient engagement in clinical guidelines development: input from > 1000 members of the Canadian Osteoporosis Patient Network.
    Osteoporos Int. 2019 Dec 14. pii: 10.1007/s00198-019-05248.
    PubMed     Abstract available


  472. TSVETOV G, Amitai O, Shochat T, Shimon I, et al
    Denosumab-induced hypocalcemia in patients with osteoporosis: can you know who will get low?
    Osteoporos Int. 2019 Dec 14. pii: 10.1007/s00198-019-05261.
    PubMed     Abstract available


  473. MERLIJN T, Swart KMA, van der Horst HE, Netelenbos JC, et al
    Fracture prevention by screening for high fracture risk: a systematic review and meta-analysis.
    Osteoporos Int. 2019 Dec 14. pii: 10.1007/s00198-019-05226.
    PubMed     Abstract available


  474. RASMUSSEN NH, Dal J, de Vries F, van den Bergh JP, et al
    Diabetes and fractures: new evidence of atypical femoral fractures?
    Osteoporos Int. 2019 Dec 14. pii: 10.1007/s00198-019-05224.
    PubMed     Abstract available


  475. GAI QY, Lv H, Li YP, Fu QM, et al
    Education intervention for older adults with osteoporosis: a systematic review.
    Osteoporos Int. 2019 Dec 11. pii: 10.1007/s00198-019-05166.
    PubMed     Abstract available


  476. PRINS JTH, Van Lieshout EMM, Reijnders MRL, Verhofstad MHJ, et al
    Rib fractures after blunt thoracic trauma in patients with normal versus diminished bone mineral density: a retrospective cohort study.
    Osteoporos Int. 2019 Dec 11. pii: 10.1007/s00198-019-05219.
    PubMed     Abstract available


  477. ADAS-OKUMA MG, Maeda SS, Gazzotti MR, Roco CM, et al
    COPD as an independent risk factor for osteoporosis and fractures.
    Osteoporos Int. 2019 Dec 6. pii: 10.1007/s00198-019-05235.
    PubMed     Abstract available


  478. HOWE JG, Hill RS, Stroncek JD, Shaul JL, et al
    Treatment of bone loss in proximal femurs of postmenopausal osteoporotic women with AGN1 local osteo-enhancement procedure (LOEP) increases hip bone mineral density and hip strength: a long-term prospective cohort study.
    Osteoporos Int. 2019 Dec 4. pii: 10.1007/s00198-019-05230.
    PubMed     Abstract available


  479. NASOMYONT N, Hornung LN, Wasserman H
    Intravenous bisphosphonate therapy in children with spinal muscular atrophy.
    Osteoporos Int. 2019 Dec 2. pii: 10.1007/s00198-019-05227.
    PubMed     Abstract available


  480. XIAO X, Wu Q
    Association between a literature-based genetic risk score and bone mineral density of African American women in Women Health Initiative Study.
    Osteoporos Int. 2019 Dec 1. pii: 10.1007/s00198-019-05244.
    PubMed     Abstract available


  481. EBELING PR, Chan DC, Lau TC, Lee JK, et al
    Secondary prevention of fragility fractures in Asia Pacific: an educational initiative.
    Osteoporos Int. 2019 Dec 1. pii: 10.1007/s00198-019-05197.
    PubMed     Abstract available


    November 2019
  482. O'SULLIVAN LM, Allison H, Parle EE, Schiavi J, et al
    Secondary alterations in bone mineralisation and trabecular thickening occur after long-term estrogen deficiency in ovariectomised rat tibiae, which do not coincide with initial rapid bone loss.
    Osteoporos Int. 2019 Nov 30. pii: 10.1007/s00198-019-05239.
    PubMed     Abstract available


  483. MILLER PD, Pannacciulli N, Malouf-Sierra J, Singer A, et al
    Efficacy and safety of denosumab vs. bisphosphonates in postmenopausal women previously treated with oral bisphosphonates.
    Osteoporos Int. 2019 Nov 28. pii: 10.1007/s00198-019-05233.
    PubMed     Abstract available


  484. OH HJ, Yoon BH, Ha YC, Suh DC, et al
    The change of bone mineral density and bone metabolism after gastrectomy for gastric cancer: a meta-analysis.
    Osteoporos Int. 2019 Nov 27. pii: 10.1007/s00198-019-05220.
    PubMed     Abstract available


  485. VAN DORT MJ, Driessen JHM, Geusens P, Romme EAPM, et al
    Association between vertebral fractures and coronary artery calcification in current and former smokers in the ECLIPSE cohort.
    Osteoporos Int. 2019 Nov 25. pii: 10.1007/s00198-019-05218.
    PubMed     Abstract available


  486. PALCU P, Munce S, Jaglal SB, Allin S, et al
    Understanding patient experiences and challenges to osteoporosis care delivered virtually by telemedicine: a mixed methods study.
    Osteoporos Int. 2019 Nov 23. pii: 10.1007/s00198-019-05182.
    PubMed     Abstract available


  487. MORLEY J, Moayyeri A, Ali L, Taylor A, et al
    Persistence and compliance with osteoporosis therapies among postmenopausal women in the UK Clinical Practice Research Datalink.
    Osteoporos Int. 2019 Nov 22. pii: 10.1007/s00198-019-05228.
    PubMed     Abstract available


  488. CUI L, He T, Jiang Y, Li M, et al
    Predicting the intervention threshold for initiating osteoporosis treatment among postmenopausal women in China: a cost-effectiveness analysis based on real-world data.
    Osteoporos Int. 2019 Nov 21. pii: 10.1007/s00198-019-05173.
    PubMed     Abstract available


  489. BORGEN TT, Bjornerem A, Solberg LB, Andreasen C, et al
    Determinants of trabecular bone score and prevalent vertebral fractures in women with fragility fractures: a cross-sectional sub-study of NoFRACT.
    Osteoporos Int. 2019 Nov 21. pii: 10.1007/s00198-019-05215.
    PubMed     Abstract available


  490. MALMGREN L, McGuigan FE, Christensson A, Akesson KE, et al
    Kidney function and its association to imminent, short- and long-term fracture risk-a longitudinal study in older women.
    Osteoporos Int. 2019 Nov 21. pii: 10.1007/s00198-019-05152.
    PubMed     Abstract available


  491. HOFF M, Skovlund E, Skurtveit S, Meyer HE, et al
    Proton pump inhibitors and fracture risk. The HUNT study, Norway.
    Osteoporos Int. 2019 Nov 18. pii: 10.1007/s00198-019-05206.
    PubMed     Abstract available


  492. LOFFLER MT, Sollmann N, Mei K, Valentinitsch A, et al
    X-ray-based quantitative osteoporosis imaging at the spine.
    Osteoporos Int. 2019 Nov 14. pii: 10.1007/s00198-019-05212.
    PubMed     Abstract available


  493. JANSZ TT, Goto NA, van Ballegooijen AJ, Willems HC, et al
    The prevalence and incidence of vertebral fractures in end-stage renal disease and the role of parathyroid hormone.
    Osteoporos Int. 2019 Nov 14. pii: 10.1007/s00198-019-05187.
    PubMed     Abstract available


  494. LEE K, Lim S, Park H, Woo HY, et al
    Subclinical thyroid dysfunction, bone mineral density, and osteoporosis in a middle-aged Korean population.
    Osteoporos Int. 2019 Nov 13. pii: 10.1007/s00198-019-05205.
    PubMed     Abstract available


  495. KANIS JA, Harvey NC, McCloskey E, Bruyere O, et al
    Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures.
    Osteoporos Int. 2019 Nov 13. pii: 10.1007/s00198-019-05176.
    PubMed     Abstract available


  496. JIANG H, Robinson DL, Yates CJ, Lee PVS, et al
    Peripheral quantitative computed tomography (pQCT)-based finite element analysis provides enhanced diagnostic performance in identifying non-vertebral fracture patients compared with dual-energy X-ray absorptiometry.
    Osteoporos Int. 2019 Nov 13. pii: 10.1007/s00198-019-05213.
    PubMed     Abstract available


  497. BARKER KL, Newman M, Stallard N, Leal J, et al
    Physiotherapy rehabilitation for osteoporotic vertebral fracture-a randomised controlled trial and economic evaluation (PROVE trial).
    Osteoporos Int. 2019 Nov 12. pii: 10.1007/s00198-019-05133.
    PubMed     Abstract available


  498. WANG Y, Yu S, Hsu C, Tsai C, et al
    Underestimated fracture risk in postmenopausal women-application of the hybrid intervention threshold.
    Osteoporos Int. 2019 Nov 6. pii: 10.1007/s00198-019-05201.
    PubMed     Abstract available


  499. MINISOLA S, Colangelo L, Cipriani C, Pepe J, et al
    FGF 23 and trabecular microarchitecture.
    Osteoporos Int. 2019;30:2357.
    PubMed    


  500. RUPP T, Amling M, Rolvien T
    FGF23 and bone microarchitecture.
    Osteoporos Int. 2019;30:2359.
    PubMed    


    October 2019
  501. KANIS JA, Cooper C, Rizzoli R, Reginster JY, et al
    Correction to: European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
    Osteoporos Int. 2019 Oct 31. pii: 10.1007/s00198-019-05184.
    PubMed     Abstract available


  502. HALLIT S, El Hage C, Hajj A, Salameh P, et al
    Construction and validation of the Lebanese Osteoporosis Knowledge Scale among a representative sample of Lebanese women.
    Osteoporos Int. 2019 Oct 30. pii: 10.1007/s00198-019-05192.
    PubMed     Abstract available


  503. ALARKAWI D, Bliuc D, Tran T, Ahmed LA, et al
    Impact of osteoporotic fracture type and subsequent fracture on mortality: the Tromso Study.
    Osteoporos Int. 2019 Oct 26. pii: 10.1007/s00198-019-05174.
    PubMed     Abstract available


  504. SOGAARD AJ, Magnus JH, Bjornerem A, Holvik K, et al
    Grip strength in men and women aged 50-79 years is associated with non-vertebral osteoporotic fracture during 15 years follow-up: The Tromso Study 1994-1995.
    Osteoporos Int. 2019 Oct 25. pii: 10.1007/s00198-019-05191.
    PubMed     Abstract available


  505. LESLIE WD
    Bisphosphonates and lower mortality risk: when it sounds to be good to be true ....
    Osteoporos Int. 2019 Oct 19. pii: 10.1007/s00198-019-05157.
    PubMed    


  506. KENDLER DL, Bone HG, Massari F, Gielen E, et al
    Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab.
    Osteoporos Int. 2019 Oct 18. pii: 10.1007/s00198-019-05146.
    PubMed     Abstract available


  507. ANAGNOSTIS P, Lambrinoudaki I, Kenanidis E, Potoupnis M, et al
    Drug holidays in osteoporosis treatment: mind the gaps!
    Osteoporos Int. 2019 Oct 15. pii: 10.1007/s00198-019-05027.
    PubMed    


  508. NAYAK S, Greenspan SL
    Bisphosphonate drug holidays.
    Osteoporos Int. 2019 Oct 15. pii: 10.1007/s00198-019-05107.
    PubMed    


  509. PARSONS CM, Harvey N, Shepstone L, Kanis JA, et al
    Systematic screening using FRAX((R)) leads to increased use of, and adherence to, anti-osteoporosis medications: an analysis of the UK SCOOP trial.
    Osteoporos Int. 2019 Oct 12. pii: 10.1007/s00198-019-05142.
    PubMed     Abstract available


  510. CORNELISSEN D, Boonen A, Bours S, Evers S, et al
    Understanding patients' preferences for osteoporosis treatment: the impact of patients' characteristics on subgroups and latent classes.
    Osteoporos Int. 2019 Oct 12. pii: 10.1007/s00198-019-05154.
    PubMed     Abstract available


  511. EBELING PR, Cicuttini F, Scott D, Jones G, et al
    Promoting mobility and healthy aging in men: a narrative review.
    Osteoporos Int. 2019;30:1911-1922.
    PubMed     Abstract available


  512. CUI Y, Lix LM, Yang S, Morin SN, et al
    A population-based study of postfracture care in Manitoba, Canada 2000/2001-2014/2015.
    Osteoporos Int. 2019;30:2119-2127.
    PubMed     Abstract available


    September 2019
  513. LO JC, Grimsrud CD, Ott SM, Chandra M, et al
    Atypical femur fracture incidence in women increases with duration of bisphosphonate exposure.
    Osteoporos Int. 2019 Sep 25. pii: 10.1007/s00198-019-05112.
    PubMed     Abstract available


  514. HUNG WC, Yang CH, Cheng WL, Wu CH, et al
    Revisit three "I" model: a novel five "I" model of fracture liaison service.
    Osteoporos Int. 2019 Sep 11. pii: 10.1007/s00198-019-05090.
    PubMed    


  515. GONZALEZ-QUEVEDO D, Bautista-Enrique D, Perez-Del-Rio V, Bravo-Bardaji M, et al
    Fracture liaison service and mortality in elderly hip fracture patients: a prospective cohort study.
    Osteoporos Int. 2019 Sep 11. pii: 10.1007/s00198-019-05153.
    PubMed     Abstract available


  516. LIU Y, Li Z, Arioka M, Wang L, et al
    WNT3A accelerates delayed alveolar bone repair in ovariectomized mice.
    Osteoporos Int. 2019;30:1873-1885.
    PubMed     Abstract available


  517. VAN MAREN MA, Wyers CE, Driessen JHM, Visser JV, et al
    Two-year persistence with teriparatide improved significantly after introduction of an educational and motivational support program.
    Osteoporos Int. 2019;30:1837-1844.
    PubMed     Abstract available


  518. BAN JK, Hao BB, McCarthy L, Guilcher SJT, et al
    Denosumab utilization among older adults in Ontario: patient characteristics, persistence with therapy, and return to therapy after an extended gap.
    Osteoporos Int. 2019;30:1865-1872.
    PubMed     Abstract available


  519. LIU D, Chen L, Dong S, Peng Z, et al
    Bone mass density and bone metabolism marker are associated with progression of carotid and cardiac calcified plaque in Chinese elderly population.
    Osteoporos Int. 2019;30:1807-1815.
    PubMed     Abstract available


    August 2019
  520. LESLIE WD, Morin SN, Lix LM, Martineau P, et al
    Fracture prediction from self-reported falls in routine clinical practice: a registry-based cohort study.
    Osteoporos Int. 2019 Aug 2. pii: 10.1007/s00198-019-05106.
    PubMed     Abstract available


  521. DE SA CAVALCANTE D, da Silva Castro MG, Quidute ARP, Martins MRA, et al
    Evaluation of bone texture imaging parameters on panoramic radiographs of patients with Sheehan's syndrome: a STROBE-compliant case-control study.
    Osteoporos Int. 2019 Aug 2. pii: 10.1007/s00198-019-05086.
    PubMed     Abstract available


  522. PEPE J, Cipriani C, Cecchetti V, Ferrara C, et al
    Patients' reasons for adhering to long-term alendronate therapy.
    Osteoporos Int. 2019;30:1627-1634.
    PubMed     Abstract available


    July 2019
  523. KWAK MK, Lee EJ, Park JW, Park SY, et al
    CD4 T cell count is inversely associated with lumbar spine bone mass in HIV-infected men under the age of 50 years.
    Osteoporos Int. 2019;30:1501-1510.
    PubMed     Abstract available


    June 2019
  524. MASSERA D, Xu S, Walker MD, Valderrabano RJ, et al
    Biochemical markers of bone turnover and risk of incident hip fracture in older women: the Cardiovascular Health Study.
    Osteoporos Int. 2019 Jun 21. pii: 10.1007/s00198-019-05043.
    PubMed     Abstract available


  525. HOIBERG MP, Rubin KH, Holmberg T, Rothmann MJ, et al
    Use of antiosteoporotic medication in the Danish ROSE population-based screening study.
    Osteoporos Int. 2019;30:1223-1233.
    PubMed     Abstract available


  526. CAIROLI E, Eller-Vainicher C, Morlacchi LC, Tarsia P, et al
    Bone involvement in young adults with cystic fibrosis awaiting lung transplantation for end-stage respiratory failure.
    Osteoporos Int. 2019;30:1255-1263.
    PubMed     Abstract available


    May 2019
  527. AHN SH, Kim JH, Cho YY, Suh S, et al
    The effects of cortisol and adrenal androgen on bone mass in Asians with and without subclinical hypercortisolism.
    Osteoporos Int. 2019;30:1059-1069.
    PubMed     Abstract available


  528. CHRISTENSEN GL, Halgreen JR, Milenkovski M, Kose A, et al
    Bone turnover markers are differentially affected by pre-analytical handling.
    Osteoporos Int. 2019;30:1137-1141.
    PubMed     Abstract available


  529. LI C, Huang Q, Yang R, Dai Y, et al
    Gut microbiota composition and bone mineral loss-epidemiologic evidence from individuals in Wuhan, China.
    Osteoporos Int. 2019;30:1003-1013.
    PubMed     Abstract available


    April 2019
  530. ARIAS-MORENO AJ, Hosseini HS, Bevers M, Ito K, et al
    Validation of distal radius failure load predictions by homogenized- and micro-finite element analyses based on second-generation high-resolution peripheral quantitative CT images.
    Osteoporos Int. 2019 Apr 17. pii: 10.1007/s00198-019-04935.
    PubMed     Abstract available


  531. TAIPALE H, Rysa J, Hukkanen J, Koponen M, et al
    Long-term thiazide use and risk of low-energy fractures among persons with Alzheimer's disease-nested case-control study.
    Osteoporos Int. 2019 Apr 16. pii: 10.1007/s00198-019-04957.
    PubMed     Abstract available


  532. PASQUALINI L, Ministrini S, Lombardini R, Bagaglia F, et al
    Effects of a 3-month weight-bearing and resistance exercise training on circulating osteogenic cells and bone formation markers in postmenopausal women with low bone mass.
    Osteoporos Int. 2019;30:797-806.
    PubMed     Abstract available


  533. KUMAR P, Singh NK, Gargeshwari A, S R, et al
    Changes in middle ear transmission characteristics secondary to altered bone remodelling.
    Osteoporos Int. 2019;30:863-870.
    PubMed     Abstract available


    March 2019
  534. BURIAN E, Subburaj K, Mookiah MRK, Rohrmeier A, et al
    Texture analysis of vertebral bone marrow using chemical shift encoding-based water-fat MRI: a feasibility study.
    Osteoporos Int. 2019 Mar 22. pii: 10.1007/s00198-019-04924.
    PubMed     Abstract available


  535. BEAUDOIN C, Moore L, Gagne M, Bessette L, et al
    Performance of predictive tools to identify individuals at risk of non-traumatic fracture: a systematic review, meta-analysis, and meta-regression.
    Osteoporos Int. 2019 Mar 14. pii: 10.1007/s00198-019-04919.
    PubMed     Abstract available


    January 2019
  536. BEZERRA DE CARVALHO KS, Vasco RFV, Custodio MR, Jorgetti V, et al
    Chronic kidney disease is associated with low BMD at the hip but not at the spine.
    Osteoporos Int. 2019 Jan 28. pii: 10.1007/s00198-019-04864.
    PubMed     Abstract available


  537. TAMAKI J, Fujimori K, Ikehara S, Kamiya K, et al
    Estimates of hip fracture incidence in Japan using the National Health Insurance Claim Database in 2012-2015.
    Osteoporos Int. 2019 Jan 16. pii: 10.1007/s00198-019-04844.
    PubMed     Abstract available


  538. FUJITA K, Kaburagi H, Nimura A, Miyamoto T, et al
    Lower grip strength and dynamic body balance in women with distal radial fractures.
    Osteoporos Int. 2019 Jan 4. pii: 10.1007/s00198-018-04816.
    PubMed     Abstract available


    December 2018
  539. GEUSENS P, van den Bergh J
    Comments on Kanis et al.: Characteristics of recurrent fractures.
    Osteoporos Int. 2018 Dec 18. pii: 10.1007/s00198-018-4735.
    PubMed    


    April 2018
  540. DELL R, Greene D
    A proposal for an atypical femur fracture treatment and prevention clinical practice guideline.
    Osteoporos Int. 2018 Apr 19. pii: 10.1007/s00198-018-4506.
    PubMed     Abstract available


    February 2018
  541. WU CH, Kao IJ, Hung WC, Lin SC, et al
    Economic impact and cost-effectiveness of fracture liaison services: a systematic review of the literature.
    Osteoporos Int. 2018 Feb 19. pii: 10.1007/s00198-018-4411.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Osteoporosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: